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ABSTRACT
Metal-containing polymers or metallopolymers, are one of the major classes of 
polymers which stand out independently because of a unique combination of organic and 
inorganic components in one macromolecular system. Among the variety of 
metallopolymers, metallocene-containing polymers have been widely utilized for 
applications ranging from electrochemical sensors to templates for advanced inorganic 
catalysts to battery materials, due to their unique physicochemical properties. This 
dissertation is focused on the synthesis, characterization, and application of cationic 
metallocene-containing polymeric materials. Cationic-cobaltocenium was grafted in 
various inorganic nanoparticles using polymerization techniques such as reversible 
addition-fragmentation chain transfer polymerization. 
In Chapter 1, the overall background of metallopolymers, antimicrobial polymers 
and modification of nanoparticle polymerization methods is included. Chapter 2 focuses 
on the study of electrostatic charge on the relative affinity and comparison of the relative 
binding strength of a cobaltocenium-containing polyelectrolyte. The nature and relative 
strength of intermolecular interaction between cationic polyelectrolytes and anionic probes 
were investigated. Chapter 3-4 reports the preparation of inorganic silica and iron oxide 
nanoparticles grafted with charged cobaltocenium-containing metallopolymers by surface-
initiated reversible addition-fragmentation chain transfer (RAFT) polymerization. In 
Chapter 5, cobaltocenium-containing polymers were coated on gold nanoparticles by a 
vii 
grafting-to mechanism.  β-lactam antibiotic like penicillin-G were then conjugated with all 
the nanoparticles by ion-pairing between the cationic cobaltocenium moiety in the 
nanoparticles and carboxylate anions of antibiotics. Such bio-conjugated nanoparticles not 
only reduced the activity of β-lactamase but effectively lysed both Gram-positive and 
Gram-negative bacterial cells.  All these nanoparticles were characterized and subjected 
for antimicrobial evaluation against a range of bacteria and biocompatibility with 
mammalian cells.  
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CHAPTER 1 
GENERAL INTRODUCTION
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1.1 Metallocene-containing Polymers  
Metal-containing polymers or metallopolymers are a new class of materials which 
show interesting properties and use as they have processing advantages of polymers and 
functionalities provided by metal centers. During the past several decades, 
metallopolymers have been widely studied due to their diverse applications as optic, 
electronic, and magnetic materials, catalysts, and ceramic precursors.1, 2 Metallocene-based 
polymers represent classical metallopolymers by incorporating functional sandwich-
structured metallocenes into polymer materials.3-5 The first member of the metallocene 
family, ferrocene, was introduced by Geoffrey Wilkinson and Ernst Otto Fischer in early 
1950s.6 Ferrocene is the most widely studied metallocene which has received a lot of 
attention. Tremendous progress has been made in the last two decades in the field of 
ferrocene-containing polymers.7-10 Generally, there are two major states of a metallocene: 
the neutral metallocene and the cationic metallocenium. Neutral metallocenes, 
predominantly 18 electron ferrocene and ruthenocene, have been widely explored. In 
comparison to ferrocene, cobaltocene and cobaltocene containing polymers have received 
far less attention and have been much less explored. One of the main reasons behind the 
limited research is due to the difficulty in synthesizing substituted derivatives of 
cobaltocene. Ferrocene has 18 valence electrons and can easily undergo electrophilic 
aromatic substitution reactions. Cobaltocene has 19 valence electrons and readily oxidizes 
to cobaltocenium, which is incapable of undergoing electrophilic aromatic substitution 
reactions due to its great stability and inertness. Due to the high chemical stability of 
cobaltocenium, it is challenging to make cobaltocenium-containing derivatives by direct 
substitution on cyclopentadiene ring.  
 
 
3 
  Different from neutral ferrocene-containing polymers, cobaltocenium-containing 
polymers are quite unique due to their charged state and highly stable chemical property.11-
13 The charged state poses a considerable challenge to synthesize mono-substituted 
cobaltocenium, which is the initial step to prepare side-chain cobaltocenium-containing 
polymers. The pioneer work on cobaltocenium-containing polymers was done by Sheats 
et. al. that focused on the synthesis of main-chain cobaltocenium-containing oligomers 
with poor solubility.14, 15 Manners et. al. did notable work using ring-opening 
polymerization (ROP) techniques to prepare well defined main-chain cobaltocenium 
polymers such as ring-tilted dicarba[2]cobaltococenophane in an effort to overcome the 
problem. However, anionic ROP gave oligomers with degree of polymerization less than 
9.16  The two important aspects that plays a crucial role in synthesizing cobaltocenium-
containing polymers are: (i) synthesis of mono-substituted cobaltocenium, which can be 
further converted to polymerizable monomers; (ii) control over the polymer structure. 
Controlled polymerization techniques such as atom transfer radical polymerization 
(ATRP), RAFT and ring-opening metathesis polymerization (ROMP) could offer a good 
control on molecular weight, architecture and functionality as well as low dispersity. 
Mono-substituted cobaltocenium has been synthesized by using a statistical reaction 
between methyl cyclopentadiene, cyclopentadiene and cobalt bromide, followed by further 
oxidation and exhausted separation to give cobaltocenium monoacid, which can be further 
converted into vinyl monomers (method 1 in Scheme 1). Due to the nature of the statistical 
reaction, the synthetic methodology is very tedious with a low yield (less than 10%). 
Another method developed independently around the same time by Blidstein17 and Tang18 
uses a reaction between un-substituted cobaltocenium and a nucleophile based on 
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organolithium reagents, followed by hydride abstraction to give mono-substituted 
cobaltocenium (method 2 in Scheme 1). 
Scheme 1.1 Different methods to synthesize mono-substituted cobaltocenium with various 
functional groups 
 
This method not only improves the yield but also results in ethynylcobaltocenium, 
which can react with different azides through a copper-catalyzed azide-alkyne 
cycloaddition (CuAAC) to give mono-substituted cobaltocenium with different functional 
groups. Different from the main-chain polymers, Tang group established a synthetic 
platform to prepare side-chain cobaltocenium-containing polymers with high molecular 
weight and low dispersity.19-22 They used a direct synthesis route to prepare monomers by 
obtaining monosubstituted cobaltocenium-containing compounds instead of using 
electrophilic substitution reactions. The obtained mono-functionalized cobaltocenium 
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carboxylic acid was then modified into various polymerizable groups to result in a variety 
of polymers.22-25 
1.2 Antimicrobial Polymers  
Antimicrobial peptides (AMPs) are natural cationic amphiphilic peptides which act 
as the first line of defense to prevent organisms from various microbial infections. Even 
though there has been a prolonged discussion over bactericidal mechanism of AMPs, it is 
commonly acceptable that AMPs could adopt amphipathic structures to associate with 
bacterial membranes. The cationic part is believed to interact with negatively charged 
bacteria to disrupt the membrane.26 However, the toxicity and the ability of AMPs to lyse 
eukaryotic cells is a major hurdle to overcome before their use. Also, the peptides 
themselves are vulnerable to proteolysis and hence degrade too rapidly once in the body, 
and are often immunogenic in vivo. In addition, many AMPs are very expensive, limiting 
their use in large scale. Inspired by the AMPs, synthetic macromolecules have been 
introduced as antimicrobial agents. Rather than targeting proteins as most β-lactam 
antibiotics do, cationic polymers27-33 can disrupt membranes, and have shown efficacy 
against bacteria. Synthesis of cationic polymers is not labor-intensive, so the production in 
a large scale is quite feasible. For example, poly(vinyl alcohol)s34, polyacrylates35, 
polyimines36, polystyrenes37, polysiloxanes38, and polyurethanes35 have been 
functionalized with various cationic moieties to be used as an antibacterial agents. In Gram-
positive bacteria, teichoic acids are linked to either the peptidoglycan cell wall or to the 
underlying cell membrane to impart net negative charges because of the presence of 
phosphate moieties in their structure. While an additional outer membrane bearing 
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phospholipids and lipopolysaccharides is present in Gram-negative bacteria, the strongly 
negative charges to cell surface is imparted by lipopolysaccharides.  
Currently the majority of synthetic antimicrobial agents are compounds or 
polymers having cationic functional groups, which promote rapid adsorption onto the 
negatively-charged bacterial cell surfaces. The surface of eukaryotic cell membranes is 
composed of zwitterionic phospholipids such as phosphatidylcholine, cholesterol and 
sphingomyelin, so only interacts weakly with cationic species. The cationic polymers 
interact with bacterial membrane initially by electrostatic interaction and then the 
hydrophobic side chains insert into the membranes via hydrophobic interactions with the 
fatty tails of membrane phospholipids, causing the membrane to depolarize and the cell 
death. However, most of these strategies have been restricted by their limitations, such as 
the high toxicity of cationic polymers and peptides, poor release of antibiotics, and low 
targeting efficiency toward bacteria.39, 40 
1.3 Nanoparticles 
Nanoparticles are objects ranging in size from 1-100 nm. Nanoparticles usually 
have novel physical and chemical properties when compared to their larger-sized (bulk) 
counterparts, such as greater chemical reactivity and useful optical features (e.g., strong 
visible fluorescence).41  Such properties are being executed for various applications, from 
medical treatments, using in various branches of industry production such as solar and 
oxide fuel batteries for energy storage, to diverse materials of everyday use such as 
cosmetics or clothes.39, 42 The nanoparticles have large surface area/volume ratio and tend 
to agglomerate into large clusters losing the specific properties associated with their 
nanometer dimensions. Therefore, appropriate surface modification and particle 
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stabilization plays a crucial role in extending the utility of nanoparticles into 
bioapplications. Nanoparticles are often coated with polymers to prevent from aggregation 
or degradation. Traditionally polymers are usually coated on nanoparticles by 
physisorption to provide a passivation layer in colloidal chemistry. Another method 
employs polyelectrolytes as the coating materials using coulombic attraction between 
charged nanoparticles and the oppositely charged polyelectrolyte polymer. The thickness 
of the coating is controlled by depositing additional layers of opposite charged 
polyelectrolytes. However, not all polymers are available in polyelectrolyte form so this 
approach is quite limited. More pragmatic attachment of polymers to nanoparticle surfaces 
is through covalent linkages by two common approaches: grafting onto43-46 and grafting-
from47-50. The grafting to method involves the synthesis of a polymer with a reactive end 
group that is attached to the surface of the nanoparticle. By this approach polymers are 
end-functionalized and can react with surface functionalities on the nanoparticles. This 
method allows explicit control of the molecular weight (Mn) and polydispersity index 
(PDI). Alternatively, grafting from involves in situ polymerization of monomers directly 
from the nanoparticles. While the grafting from approach promises high grafting ratios, it 
typically requires the attachment of an initiating group prior to polymerization.
 
Figure 1.1 Two strategies to modify nanoparticles surface with polymers 
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1.4 Polymerization Techniques  
Reversible Addition Fragmentation Chain Transfer Polymerization (RAFT). RAFT 
polymerization is a common controlled radical polymerization technique that was 
developed in late 1990s at CSIRO. It can obtain predetermined molecular weight, and 
narrow molecular weight distributions.51-53 The RAFT process consists of traditional free 
radical polymerization of a monomer in the presence of a chain transfer agent, also known 
as RAFT agent or chain transfer agent. The chemical structure of a RAFT agent typically 
has a dithioester group (S=C-S) with substituents R and Z that impact the polymerization 
kinetics. The Z groups are chosen in such a way that to stabilize propagating radicals while 
the R group plays a vital role to the initiation of the radical intermediate and its ability to 
fragment. Phenyl group is most often encountered as the Z group in RAFT agent. The best 
R groups are those that have steric hindrance and contain an electron withdrawing group. 
The most widely used R groups are cumyl and cyanoisopropyl groups.  
 
Figure 1.2 Overall mechanism of RAFT polymerization 
Currently dithiobenzoates are the most commonly used RAFT agents because of 
their ability to show control over various monomers and radical initiators. RAFT 
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polymerization has been used to prepared polymers of complex architectures, including 
block copolymers, brush polymers and dendrimers. 
Ring-Opening Metathesis Polymerization (ROMP). ROMP is a recently-developed 
polymerization method which is an attractive technique to prepare new polymers with 
controlled molecular architectures. It is robust, high efficient, and easy to operate.54 ROMP 
is an olefin metathesis chain-growth polymerization and the overall mechanism of ROMP 
is metal-mediated carbon-carbon double bond exchange with release of the ring strain 
energy as the driving force.55 Polymers prepared by ROMP contain unsaturated double 
bonds in each repeating unit. The catalysts used in ROMP includes a variety of metals and 
the most well-known, high efficient catalysts are ruthenium based Grubbs’ catalysts. Figure 
1.7 shows the three different generations of Grubbs catalysts. 
 
Figure 1.3 Grubbs catalysts for ROMP 
1.5 Dissertation Outline 
Inspired by the advance of metal-containing small molecular drugs and promoted 
by the great progress in polymer chemistry, metal-containing polymers have gained 
momentum during recent decades. In addition, the emergence of drug-resistant bacteria 
necessitates the development of new antimicrobial agents. The objectives of this 
dissertation are blended on those two areas of research. The goal of this dissertation is to 
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investigate cationic cobaltocenium polyelectrolytes and also prepare novel cobaltocenium-
containing materials for antimicrobial application.   
Chapter 2 describes study of binding of cobaltocenium-containing polyelectrolytes 
with various anion probes using optical spectroscopy methods. The effect of various factors 
like electrostatic charge, conformation, size of anionic probes was investigated. Also, the 
polyelectrolyte complexes between a cationic cobaltocenium polymer and an anionic 
polymer were prepared to compare with a cationic quaternary ammonium polymer along 
with the study of comparative binding strength. 
Chapter 3 focuses on the synthesis of a nontraditional strategy of resurrecting the 
traditional antibiotics by complexing with charged metallopolymer-grafted silica 
nanoparticles. This method not only saves the time but also ensures improved activity 
against both Gram-positive and Gram-negative bacteria.  
Chapter 4 focuses on design and synthesis of highly efficient charged 
metallopolymer-grafted magnetic nanoparticles via surface-initiated RAFT 
polymerization. These nanoparticles displayed a response to external magnetic fields and 
were easily recycled after antibacterial tests. The recycled nanoparticle conjugates retained 
aqueous dispersibility and high antibacterial efficacy. 
In Chapter 5, a strategy to prepare ultra-small cobaltocenium-containing 
nanoparticles using grafting-to mechanism is presented. The thiol end-capped 
cobaltocenium polymers were coated on gold nanoparticle surface and complexed with 
anionic penicillin-G to be used against notorious pathogens. 
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Finally, a summary is given in Chapter 6. In addition, some suggestions about 
continued and future research of cobaltocenium-containing polymers are provided.  
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CHAPTER 2 
BINDING OF COBALTOCENIUM-CONTAINING POLYELECTROLYTES WITH 
ANIONIC PROBES1 
                                                          
1 Pageni, P.; Kabir, M.P.; Yang, P.; Tang, C. Binding of Cobaltocenium-Containing 
Polyelectrolytes with Anionic Probes. J. Inorg. Organomet. Polym., 2017, 27, 1100-1109. 
Reprinted here with permission of publisher. 
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2.1 Abstract 
 Cationic cobaltocenium-containing polyelectrolytes have a unique ability to form 
ionic complex with various anionic species. However, the relative binding strength is under 
explored. We carried out two sets of model study to compare the relative binding strength 
of a cobaltocenium-containing polyelectrolyte. Firstly, the nature and relative strength of 
intermolecular interaction between cobaltocenium-containing polyelectrolytes and 
different anionic probes were investigated by spectroscopic methods. A dye-displacement 
method was used to monitor absorbance and fluorescence emissions. Secondly, the binding 
strength of this cobaltocenium-containing polyelectrolyte was compared with a classical 
quaternary ammonium polymer. Formation of polyelectrolyte complex between the 
cobaltocenium-containing polyelectrolyte and a common anionic polyelectrolyte at various 
concentrations was examined by optical absorption and light scattering. 
2.2 Introduction 
A polyelectrolyte refers to a macromolecule with ionically charged motifs either on 
their side chain or on the backbone. It is often termed as a polymeric-electrolyte with dual 
characteristics of a polymer and an electrolyte. The most significant property of 
polyelectrolytes turns out to be the water solubility, which opens the door for various 
applications in food industry,1, 2 ultrafiltration,3, 4 waste water treatment,5, 6 fuel cells,7-10 
biomaterials11-14 and nanotechnology.15-18 Cationic polyelectrolytes have basic groups such 
as phosphonium, sulfonium, ammonium, imidazolium or pyridinium in their structure, 
while anionic polyelectrolytes have acidic groups like sulfonate, phosphate, carboxylate, 
phosphonate and arsenate.19-21 Some of the commonly used polyelectrolytes are 
polystyrene sulfonate, polyacrylic and polymethacrylic acid along with their salts, DNA 
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and other polybases and polyacids.22 There have been notable advancements made in 
designing structures with respect to the nature of ionic moieties. Cationic metallocene such 
as cobaltocenium is particularly interesting as it possesses intrinsic cationic metal center 
coupled with counterions and is a good candidate to be used as an ionic center in 
polyelectrolytes. However, synthetic challenges posed by the high chemical stability of 
cobaltocenium limits the synthesis of cobaltocenium-containing polymers.23, 24  
Most of metallocene-containing electrolytes have been exclusively based on 
ferrocene and widely utilized for applications ranging from electrochemical sensors to 
templates for advanced materials to biomedicines.25-34 Compared with ferrocene, it is 
difficult to prepare derivatives from cobaltocene or cobaltocenium by electrophilic 
substitution due to the ease in oxidation of cobaltocene and the inertness of cobaltocenium 
salts.35 Thus, the incorporation of cobaltocene/cobaltocenium into polymers has been far 
less explored than ferrocene. Most of the initial work on cobaltocenium-containing 
polymers started off with synthesis of short main-chain polymers via condensation 
polymerization.36-38 It was partly because of the straightforward synthesis of disubstituted 
cobaltocenium. Manners and coworkers were able to employ ring-opening polymerization 
(ROP) to prepare high molecular weight water soluble main-chain cobaltocenium-
containing polymers.39, 40 In addition, significant amount of efforts was directed to 
synthesize cobaltocenium-containing dendrimers.41-44 Solid phase peptide synthesis was 
utilized by Metzler-Nolte and co-workers to make series of cobaltocenium bioconjugates 
using cobaltocenium acid.45, 46 The development of practical synthesis of the 
monosubstituted cobaltocenium achieved by our group47 and others48 paved the way for 
the efficient and scalable synthesis of side-chain cobaltocenium-containing 
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polyelectrolytes. A major thrust for creating novel cobaltocenium polyelectrolytes is fueled 
by the progress in controlled free radical polymerization (CFRP) techniques.49 Recently, 
we reported the synthesis of side-chain cobaltocenium-containing polyelectrolytes and 
their applications as advanced materials.50-53 In addition, side-chain cobaltocenium-
containing polyelectrolytes were utilized as novel antimicrobial materials to kill bacteria.54 
These cobaltocenium-containing polyelectrolytes were able to rejuvenate the traditional β-
lactam antibiotics by forming an ionic interaction between carboxylic anions and cationic 
cobaltocenium moieties to inhibit the degradation of drugs. However, the effects of 
different parameters of small anionic probes such as electrostatic charge, size, 
conformation and π-electron system on the interactions of these useful polyelectrolytes 
have not been investigated. Also, the relative binding strength of these polymers in 
comparison to other cationic polymers is still a mystery. 
To explore those pristine fields, we designed two separate experiments. First, a 
qualitative study was carried out with a fluorescence dye to make a complex with polymers 
followed by the addition of small anionic probes to displace the dye. The released amount 
of dye was measured using optical absorption, which gives the relative binding affinity of 
anionic probes to polymers. The second aspect of this study was to conduct the comparative 
study of binding strength of cobaltocenium-containing polyelectrolyte with anionic 
polyelectrolyte. Formation of polyelectrolyte complex (PEC) in various concentrations was 
examined, and the optical transmittance was measured. 
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2.3 Experimental Section 
 Characterization 
1H NMR spectra (400 MHz) were recorded on a Varian Mercury 400 NMR 
spectrometer with tetramethylsilane (TMS) as an internal reference. Mass spectrometry 
was conducted on a Waters Micromass Q-TOF mass spectrometer, and the ionization 
source was positive ion electrospray. UV-vis was carried out on a Shimadzu UV-2450 
spectrophotometer with a 10.00 mm quartz cuvette and monochromatic light of various 
wavelengths over a range of 190-900 nm. Dynamic light scattering (DLS) was operated on 
a Nano-ZS instrument, model ZEN 3600 (Malvern Instruments. Fluorescence emission 
intensity was measured by using Cary Eclipse Fluorescence Spectrophotometer). 
Materials and Methods 
2-Cobaltocenium amidoethyl methacrylate hexafluorophosphate (CoAEMAPF6) 
was synthesized according to our earlier report.51 2-Aminoethyl methacrylate 
hydrochloride (90%), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(EDC-HCl, 98%), 4-(dimethylamino) pyridine and tetrabutylammonium chloride (TBACl) 
were purchased from Aldrich and used as received. Tris buffer solution was prepared from 
tris(hydroxymethyl)aminomethane (Tris base) (Sigma-Aldrich) and concentrated 
hydrochloric acid (Sigma-Aldrich). Poly(sodium styrene sulfonate) (Mn = 70,000 g/mol) 
was purchased from Sigma as an anionic polyelectrolyte. The fluorescent probe 5(6)-
carboxyfluorescein (as a mixture of isomers) was purchased from Sigma-Aldrich. 
Displacer anion solutions were prepared from succinic acid (Sigma), tricarballylic acid and 
1,4-cyclohexanedicarboxylic acid (Acros), 1,2,3,4-butanetetracarboxylic acid and pimelic 
acid (Alfa Aesar), trimesic acid and 1,3,5- cyclohexanetricarboxylic acid (TCI America). 
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Water was from Thermo Scientific with ion conductivity at 18.20 MΩ. All other chemicals 
were from commercial sources and used as received. 
Synthesis of Cationic (2-dimethylamino)ethyl methacrylate (DMAEMA) 
Neutral DMAEMA (5.00 g, 31.90 mmol) was dissolved in 30 mL of dry DCM and 
chilled to 0 ᵒ C.  Iodomethane (9.00 g, 63.80 mmol) was then added dropwise to the solution 
under stirring and reacted for 30 min at room temperature. After precipitation in ether, a 
white powder was obtained with a yield of 87%.  
Synthesis of Cationic Poly((2-dimethylamino)ethyl methacrylate) (PDMAEMA) 
Throughout this experiment cationic PDMAEMA will be used and will be referred 
as simply PDMAEMA.  Cationic DMAEMA (0.50 g, 2.42 mmol), RAFT agent (6.75 ×10-
3 g, 24.20 × 10-3 mmol) and AIBN (1.20 ×10-3 g, 7.31× 10-4 mmol) were dissolved in 1.5 
mL of dry MeOH in a 10 mL Schlenk flask and degassed by three cycles of freeze-pump-
thaw. The reaction was heated under 70 ᵒC until the desired conversion was reached and 
quenched by opening to air and cooled with ice water. The reaction was precipitated in 
acetone three times and vacuum-dried to afford a pink powder. 
 
Figure 2.1 1H NMR spectrum of poly (dimethylamino methacrylate) 
 
 
21 
Synthesis of 2-Cobaltoceniumamidoethyl Methacrylate Hexafluorophosphate 
(MAEACoPF6) 
An amidation reaction was employed to synthesize MAEACoPF6. Cobaltocenium 
carboxylic acid hexafluorophosphate (2.00 g, 5.29 mmol), 2-aminoethyl methacrylate 
hydrochloride (0.94 g, 5.68 mmol), and 4-(dimethylamino) pyridine (0.13 g, 1.06 mmol) 
were dissolved in 20 mL dry acetonitrile and the solution was cooled to 0 oC. Solution of 
EDC-HCl (1.10 g, 5.74 mmol) was then slowly added into previously cooled solution. 
Then, dry triethylamine (1.60 g, 15.80 mmol) was added into the reaction. The reaction 
was stirred for 4 hours. Solution was then extracted by saturated sodium 
hexafluorophosphate aqueous solution three times to remove unreacted starting materials. 
The organic phase was collected, condensed and precipitated into diethyl ether. Yellow 
solid was collected and dried under vacuum overnight. Yield: 1.60 g, 58%. 1H NMR 
(CD3COCD3, δ, ppm): 8.30 (broad, NHCH2, 1H), 6.42 (t, Cp, 2H), 6.22 (m, CH2C, 1H), 
6.10 (t, Cp, 2H), 5.92 (s, Cp, 5H), 5.62 (m, CH2C, 1H), 4.42 (m, OCH2CH2NH, 2H), 3.66 
(m, OCH2CH2NH, 2H), 1.94 (m, CH3CCO, 3H).  
 
Figure 2.2. 1H NMR spectrum of cobaltocenium monomer CoAEMAPF6 in CD3COCD3 
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Synthesis of Poly(2-(methacrylolyamide) ethyl cobaltoceniumcarboxylate 
hexafluorophosphate) via RAFT polymerization (PCoPF6) 
MAECoPF6 (0.30 g, 0.61 mmol), cumyl dithiobenzoate (CDB) (1.67 ×10
-3 g, 6.10 
×10-3 mmol) and AIBN (0.20 ×10-3 g, 1.23 ×10-3 mmol) were dissolved by 0.40 mL DMF 
in a 10mL Schlenk flask and then were purged with N2 for 30 min. The polymerization 
was started by heating the mixture at 90ᵒC. Samples were taken out periodically to monitor 
the monomer conversion. Once the desired conversion was reached, polymerization 
reaction was quenched by exposure to air. The reaction mixture was then precipitated in 
cold DCM three times and vacuum dried overnight. Yield: 150 ×10-3 g, 80%. 1H NMR 
(CD3CN, δ): 7.4 (broad NHCH2), 6.2, 5.9, 5.8 (m, m, s, Cp), 4.2(broad, CH2OO) 3.6 
(broad, NHCH2), 1.8 (broad, CH2C), 0.6-1.0 (broad, CCH3). 
Titration conditions 
All experiments were carried out in aqueous solutions buffered to pH 7.4 with Tris 
buffer solution at a temperature of 25 ᵒC. The pH of the working solutions was adjusted 
prior to use by addition of NaOH or HCl solution and checked during a titration to make 
sure that it stayed at the desired value of 7.4. The concentration of polyelectrolytes in all 
experiments was maintained at 1.00 ×10-6 M. 
Binding Isotherm 
Stock solutions of dye, polymer, and displacer anions in a buffered solution were 
used as starting points for all experiments. All solutions used in this study were made by 
dilution of aliquots of these stock solutions. Binding isotherm experiment was conducted 
using constant polyelectrolytes (1.00 ×10-6 M) and different fluorophore concentration. 
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Absorbance and fluorescence emission readings were blanked by subtracting the 
corresponding reading for the buffer. The resulting data were plotted as a function of the 
[polyelectrolytes]/[fluorophore] ratio to produce binding isotherms. 
General Displacement Titration Protocol 
Displacement experiments were carried out using two separate working solutions: 
a “titrant” and a “cuvette” solution. Titrant and cuvette solutions were made fresh for each 
experiment. A cuvette solution contained both the dye ([CF] = 2.00 × 10-6 M) and the 
polyelectrolyte ([P] = 1.00 × 10-6 M) at an appropriate ratio to form the desired bound dye 
complex (P-CFn). The titrant solution contained a displacer anion at an appropriate 
concentration to carry out the titration. Titrations on benchtop instruments were carried out 
by addition of different aliquots of titrant solution to a constant volume of cuvette solution. 
The total volume of mixture was kept constant by addition of buffer solution. Using this 
method, the concentration of dye and polyelectrolyte remained constant but the 
concentration of displacer anion varied throughout the titration. The resulting data from 
fluorescence and UV-vis spectroscopy were plotted as a function of the [displacer 
anion]/[fluorophore] ratio to produce fluorescence intensity and absorbance isotherms. 
Measurement of Transmittance 
A typical experiment is described as an example. 1.00 mL of 0.10 mM PCoCl and 
PDMAEMA was placed in two different glass cuvettes followed by the measurement of 
transmittance. Different volumes of PSSNa (concentration= 0.10 mM) from 0.10 mL to 
1.00 mL was added to both cuvettes. The addition of PSSNa was increased each time by 
0.10 mL and subsequent transmittance of the resulting PEC solution was measured. 
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2.4 Results and Discussion 
2.4.1 Binding of small anions with cobaltocenium-containing polymer. 
In this model study, we synthesized a cobaltocenium-containing polymer, poly 
(cobaltocenium methacrylate) (PCoCl)with molecular weight of Mn = 19,000 g/mol via 
RAFT polymerization (Scheme 2.1). The disappearance of vinyl protons from 
methacrylate monomers around 5.0- 6.2 ppm and appearance of broad peaks around 0.5-
2.0 ppm in 1H NMR spectrum suggested the successful polymerization.  
Scheme 2.1. Synthesis of poly (cobaltocenium methacrylate) by RAFT polymerization. 
 
A number of small organic probes were selected to systematically investigate the 
relative binding affinity between polyelectrolytes and anionic probes. As shown in Table 
2.1, the anionic probes in the same category differ by one key property, so that comparison 
of the relative affinities provides the important structural features for intermolecular 
interactions. The common techniques to investigate such intermolecular interactions like 
nuclear magnetic resonance (NMR) and mass spectrometry (MS) are not desirable in this 
situation. For effective NMR, higher concentration of samples is required but those 
concentrations of polymer-dye complex would result in a viscous solution with slow 
diffusion. Therefore, an optical spectroscopy method would be ideal as it is fast and 
efficient even at low concentrations.55, 56  However, neither the polyelectrolytes nor the 
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organic probes have any significant chromophore or fluorophore to monitor their binding 
ability. Thus, the introduction of a reporting agent in the system is necessary.  
Table 2.1 Anionic probes used to investigate the binding interaction with a cobaltocenium 
polymer 
Properties under study Anionic Probes  
Electrostatic Interactions succinate2- vs tricarballylate3- vs butanetetracarboxylate4- 
Guest Size succinate (short) vs pimelate (long) 
Guest Shape  tricarballylate (flexible) vs cyclohexanetricarboxylate (rigid) 
Charge –π interactions cyclohexanetricarboxylate (aliphatic) vs trimesate (aromatic) 
 
In this approach, a trianion dye, 5(6)-carboxyfluorescein (CF), was used as a 
fluorescent indicator because the binding affinity of monoanion and dianion towards 
polyelectrolytes would be too low at a lower concentration.  All experiments were 
conducted in a 50 mM aqueous Tris buffer solution with pH = 7.4 at 25ᵒC. The polymer-
dye complex (P-CFn) was firstly made as shown in Scheme 2.2, and then the 
nonfluorescent displacer probe was introduced to displace the dye from its polymer-dye 
complex to form a polymer-probe complex (P-Dm).  
Scheme 2.2 Dye displacement assay used to detect binding of spectroscopically silent 
anionic guests (D) to the polymer (P) by using tri-anionic fluorescent dye 5(6)-
carboxyfluorescein (CF). 
 
The polymer-probe complex can be monitored through the change in spectroscopic 
signature of the dye from its bound state to free state by UV-visible and fluorescence 
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emission spectroscopy. The spectroscopic signature is represented by the free dye anion. 
The ratio of the concentration of polymer to the concentration of dye is critical in the 
displacement experiment. When the polymer is used in excess, the dye would not fully 
bind to the polymer. This would result in unoccupied space in the polymer and resist any 
signal change. On the other hand, if the polymer is not enough, the excess dye would add 
to the displaced dye signature, which would result in the wrong estimation.  We found the 
polymer could bind at least 85% dye. The fluorescence intensity and absorbance isotherms 
profiles were obtained by the titrations of displacer probes into a buffered solution of the 
polymer−dye complex. By comparing isotherm profiles for different displacer anions, the 
important structural properties for the binding to these polymers can be estimated.  
i) Electrostatic charge 
The effect of the electrostatic charge on the relative affinity for cobaltocenium 
polyelectrolytes was carried out by using a series of model carboxylate anions succinate, 
propane-1,2,3-tricarboxylate, and 1,2,3,4-butanetetracarboxylate, which respectively 
represents dianionic, trianionic, and tetraanionic species. The results showed that with the 
increase in charge in a guest anion, the binding affinity increased significantly (Figure 2.3). 
On average, the increase of one negative charge in the probe could increase the relative 
binding affinity by one order of magnitude,57 highlighting the importance of electrostatic 
interactions. 
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Figure 2.3 Fluorescence intensity and absorbance isotherms from titration of a PCFn 
complex with different displacer (DP). [CF] = 1.0 × 10−6 M, [Co+] = 4.0× 10−6 M in 
buffered solution (50 mM Tris at pH 7.40), λexc = 494 nm. 
ii) Guest Conformation   
The effect of conformation of a guest anion on the relative affinity with the polymer 
was investigated by using cyclohexanetricarboxylate and tricarballylate. Both anions have 
three negative charges, but cyclohexanetricarboxylate is much more rigid due to its chair 
conformation whereas tricarballylate has less conformational restrictions because of linear 
backbone. As shown in the isotherms in Figure 2.4, the two anions showed similar binding 
affinity. 
In order to explore the effect of guest size on the relative binding affinity, succinate 
and pimelate anions were studied. Both anions have two negative charges but differ in 
carbon chain length. The electrostatic contribution in their binding to the polymer would 
be equal. The result showed no difference in the binding behavior between two linear 
anions with different chain length.  Thus, the size and conformation of the guest molecules 
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do not have significant influence on binding affinity for the cobaltocenium polymer.
 
Figure 2.4 Fluorescence and absorbance isotherms from titration of a P-CFn complex with 
trianionic displacers with different shape. [CF] = 1.0 × 10−6 M, [Co+] = 4.0 × 10−6 M in 
buffered solution (50 mM Tris at pH 7.4), λexc = 494nm. 
 
iii) π-system 
Finally, the effect of aromaticity of the displacer probe on the relative affinity was 
examined. For this purpose, Benzene- 1,3,5-tricarboxylate (trimesate) and 1,3,5-
cyclohexanetricarboxylate anions were used. Both are trianions with similar size and 
conformation but have different π- electron system.  
 
Figure 2.5 Fluorescence intensity and absorbance isotherms from titration of a P-CFn 
complex with trianionic aliphatic and aromatic guests. [CF] = 1.0 × 10−6 M, [Co+] = 4.0× 
10−6 M in buffered solution (50 mM Tris at pH 7.40), λexc = 494nm. 
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As shown in Figure 2.5，the presence of π-system on guest anion (benzene- 1,3,5-
tricarboxylate) increases the affinity for cationic cobaltocenium significantly. The 
difference on the relative affinity is due to an interaction mediated by the aromatic core of 
the trimesate anion. The positive charge in the cobaltocenium cation induces significant 
polarization of the C-H bonds in the cyclopentadiene. One of these C-H bonds in 
cyclopentadiene ring interacts with the π-electron cloud of the guest species. The overall 
process of interaction is promoted by the electrostatic charge on cobaltocenium in the 
polymer (Figure 2.6).  
 
Figure 2.6 Proposed C-H-π interaction between cobaltocenium-containing polymer and 
trimesate anion. 
2.4.2 Comparative study of binding strength of cobaltocenium-containing polymer. 
The primary goal of this part of experiment was to compare the relative binding 
strength of cobaltocenium containing polymer with quaternary ammonium-containing 
polymer. For this purpose, PEC was formed between the cationic polymers under study 
and an anionic polymer, poly (sodium styrene sulfonate) (PSSNa), through strong 
Coulomb interactions. PEC has been used for various applications ranging from industrial 
applications for coatings, binders to biomedical and biotechnological applications.58 
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Poly((2-dimethylamino)ethyl methacrylate) (PDMAEMA) is one of the widely 
used cationic polymers that have found applications in various fields as a polyelectrolyte.59-
62  Cationic PDMAEMA ( referred simply as PDMAEMA hereafter) with a similar 
structure to PCoCl was synthesized using RAFT polymerization (Scheme 2.3).  
Scheme 2.3 Synthesis of poly((2-dimethylamino)ethyl methacrylate) by RAFT 
polymerization. 
 
The degree of polymerization of both cationic polymers was controlled at 50 by 
tracking the monomer conversion during the polymerization process using 1H NMR. The 
molecular weight of PCoCl and PDMAEMA was 19,000 g/mol and 15,000 g/mol, 
respectively. Throughout the experiment, equivalent moles of PCoCl and PDMAEMA 
were used against the same volume of PSSNa to measure the optical transmittance. To get 
the quantitative results, the formation of PEC between a cationic polymer and PSSNa at 
various concentrations were examined by a UV-vis spectrophotometer at room 
temperature.  
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Figure 2.7 The transmittance of various polyelectrolyte solutions: A) 1.0 mL 0.10 mM 
PDMAEMA solution with addition of different volumes of 0.01 mM PSSNa; B) 1.0 mL 
0.10 mM PCoCl solution with addition of different volumes of 0.01 mM PSSNa; C) 1.0 
mL 0.20 mM PDMAEMA solution with addition of different volumes of 0.01 mM PSSNa 
D) 1.0 mL 0.20 mM PCoCl solution with addition of different volumes of 0.01 mM PSSNa; 
E) Transmittance ratio (Tt /To) as a function of volumes of PSSNa (mL) added with each 
concentration of PCoCl and PDMAEMA solutions at 0.10 mM; F) Transmittance ratio (Tt 
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/To) as a function of volumes of PSSNa (mL) added with each concentration of PCoCl and 
PDMAEMA solutions at 0.20 mM.  
As shown in Figure 2.7, the transmittance of polyelectrolyte solutions (Tt) was 
compared with that of deionized water (To) as described by the ratio of Tt /To as a function 
of volume of PSSNa added. The difference observed in the transmittance of PEC solution 
could provide information about the relative binding strength between cationic 
polyelectrolytes and the anionic polyelectrolyte. Initially, 1.0 mL of 0.10 mM solutions of 
PCoCl and PDMAEMA was placed in two different cuvettes, and the transmittance was 
measured separately for both polymer solutions. Then, 0.10 mL PSSNa solution (0.01 mM) 
was added to both cuvettes. The transmittance of the resulting PEC solution was measured 
accordingly. The volume of PSSNa was increased each time by 0.10 mL until it reached 
1.0 mL. The initial solutions of both cationic polymers were transparent. With the increase 
amount of PSSNa, the solutions gradually turned milky and turbid, formed opaque 
suspension, and then finally precipitated.  
 
Figure 2.8 The transmittance of various polyelectrolyte solutions: A) 1.0 mL 0.10 mM 
PCoCl solution with different concentration of 1.0 mL PSSNa; B) 1.0 mL 0.10 mM 
PDMAEMA solution with various concentrations of 1.0 mL PSSNa; C) Transmittance 
ratio (Tt /To) as a function of concentrations of PSSNa. 
The transmittance ratio clearly showed a higher decrease for PCoCl than 
PDMAEMA. When the concentration of each cationic polymer solution was 0.10 mM, the 
final transmittance caused by PCoCl was decreased to 52% as opposed to 74% by 
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PDMAEMA. The decrease in %T was even more prominent when 0.20 mM cationic 
polymer solutions were used. The final %T with PCoCl was about 41% while it was close 
to 69% for PDMAEMA.  
A separate experiment was carried out by increasing the concentration of PSSNa to 
0.02 mM, 0.03 mM and 0.07 mM. Accordingly, 1.0 mL of higher concentration PSSNa 
was added to 1.0 mL 0.01 mM cationic polymer solutions. With the addition of 1.0 mL 
0.03 mM PSSNa, the reduction in transmittance was quite noteworthy for PCoCl. It 
decreased to 45% as compared to 66% for PDMAEMA as shown in Figure 2.8. Higher 
concentrations of PSSNa provided negatively charged motifs in excess so that cationic 
polymers can bind instantly, leading to a sudden decrease in transmittance. The effect of 
higher concentration was prominent when 0.07 mM PSSNa was used. The transmittance 
of PDMAEMA decreased to 65%, while the final transmittance of PCoCl reached down to 
35%. It can be inferred that more PECs were formed in case of PSSNa-PCoCl than PSSNa-
PDMAEMA as a result of stronger binding between PSSNa and PCoCl. Any 
concentrations higher than 0.07 mM PSSNa resulted in instant precipitation. 
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Figure 2.9 Size distribution of PCoCl-PSSNa and PDMAEMA-PSSNa complexes using 
DLS. 
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We further studied the size of PEC particles resulted from the mixing of cationic 
and anionic polymers by dynamic light scattering (DLS). As shown in Figure 2.9, the 
average diameter of PDMAEMA-PSSNa particles was about 4 µm, much larger than the 
average size of 300 nm for PCoCl-PSSNa particles. Based on these findings a more 
compact structure for PCoCl-PSSNa can be speculated in comparison to PDMAEMA-
PSSNa. 
2.5 Conclusions 
In summary, we carried out two model studies to investigate the nature and relative 
strength of intermolecular interactions between cobaltocenium-containing polyelectrolytes 
and anionic probes using optical spectroscopy methods. We found that the electrostatic 
charge and the interaction with a π-electron moiety in the small molecular probes are the 
most influential factors in determining the binding affinity. However, the conformation and 
size of anionic probes do not significantly influence the binding affinity with the cationic 
polyelectrolyte. Furthermore, the polyelectrolyte complexes between a cationic 
cobaltocenium polymer and an anionic polymer were prepared to compare with a cationic 
quaternary ammonium polymer. The results demonstrated the cobaltocenium-containing 
polymer showed significantly higher binding with the anionic polymer than the quaternary 
ammonium counterpart. This work facilitated a better understanding on the fundamental 
interactions between cobaltocenium-containing polyelectrolytes and anionic probes.  
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CHAPTER 3 
CHARGED METALLOPOLYMER-GRAFTED SILICA NANOPARTICLES FOR 
ANTIMICROBIAL APPLICATIONS2
                                                          
2 Pageni, P.; Yang, P.; Chen, Y.;Huang, Y.; Bam, M.; Zhu, T.; Nagarkatti, M.;Benicewicz, 
B.; Decho A; Tang, C. Charged Metallopolymer-Grafted Silica Nanoparticles for 
Antimicrobial Applications Biomacromolecules, 2018, 19, 417-425. Reprinted here with 
permission of publisher. 
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3.1 Abstract 
Inappropriate and frequent use of antibiotics has led to the development of 
antibiotic-resistant bacteria, which cause infectious diseases that are difficult to treat. With 
the rising threat of antibiotic resistance, a need to develop effective new antimicrobial 
agents is prominent. We report antimicrobial metallopolymer nanoparticles, which were 
prepared by surface-initiated reversible addition−fragmentation chain transfer (RAFT) 
polymerization of cobaltocenium-containing methacrylate monomer from silica 
nanoparticles. These particles are capable of forming a complex with β-lactam antibiotics, 
such as penicillin, rejuvenating the bactericidal activity of antibiotic. Disk diffusion assays 
showed significantly increased antibacterial activities against both Gram-positive and 
Gram-negative bacteria. The improved efficiencies were attributed to the inhibition of 
hydrolysis of the β-lactam antibiotics, and enhancement of local antibiotics concentration 
on a nanoparticle surface. In addition, hemolysis evaluations demonstrated minimal 
toxicity to red blood cells. 
3.2 Introduction 
The widespread and excessive use of antimicrobial drugs has increased the 
endurance of microbes, making them more tolerant towards conventional antibiotics. 
Antimicrobial resistance has been highlighted as “one of the greatest threats to human 
health worldwide” by the Infectious Diseases Society of America, and the White House 
announced the National Strategy for Combating Antibiotic-Resistant Bacteria (CARB).1 
According to U.S. Centers for Disease Control and Prevention, at least 2 million people 
are affected annually by drug resistant bacteria in the U.S. alone, and 23,000 of them lose 
their lives.2 The burden created by these infections on the economy is also substantial, and 
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estimated to result in $20 billion in additional health care costs and $35 billion in lost 
productivity annually.3 As a result of antibiotic resistance, it is hard to treat major diseases 
because the drugs used are becoming progressively less effective. A variety of antibiotics 
are now being labelled ineffective, and the proliferation of bacteria is surging.  The growing 
need to develop powerful antibacterial agents is fueled by the increasing daily incidence of 
bacterial infections. Therefore, it is urgent to direct efforts towards the development of 
novel antibiotics and more-effective therapeutics strategies to tackle this escalating health 
crisis. 
The predominant synthetic microbial agents are compounds or polymers having 
cationic groups like quaternary ammonium or phosphonium, which promote rapid 
adsorption onto the negatively-charged bacterial cell surfaces.4-8 Due to the physical nature 
of membrane disruption, the possibility of developing new resistant strains reduces 
significantly. However, many of these antimicrobial agents, while effective against certain 
types of bacterial strains, are notoriously toxic toward mammalian cells, thus limiting their 
roles in battling infections.9-13 The use of nanotechnology has often been considered in 
developing alternative antimicrobial therapies. Nanoparticles have been widely used in 
pharmaceuticals, biomedicine and microbiology.14,15 Nanoparticles could be a powerful 
tool to combat bacterial infections.16 Antimicrobial agents have been constructed by both 
organic and inorganic nanoparticles such as silver,17-19 gold,20-22 zinc oxide,23, 24 titanium 
dioxide,25, 26 silica,27, 28 copper oxide,29 magnesium oxide30, carbon based nanoparticles 
such as carbon nanotubes,31-33 fullerenes,34 graphene oxide35. In particular, silica 
nanoparticles have a high chemical, thermal and colloidal stability, and have been found to 
be useful in biomedical applications due to their biocompatibility, low toxicity, low 
 
 
40 
density, capacity for encapsulation and easy synthesis.36, 37 In addition, they have larger 
surface areas, which can be functionalized using organo-silane chemistry to introduce 
desirable functional groups to regulate drug loading. The bactericidal effect of silica 
nanostructures could be fine-tuned by adjusting various parameters like particle size, shape, 
porosity and surface functionalization.38 Kim et al. synthesized dual mode silica 
nanoparticles for specific binding to his-tagged proteins for purification and labeling of 
proteins.39 Bharali et al. used amino-surface functionalized plasmid DNA-bounded silica 
nanoparticles for in vivo gene delivery.40 Lui et al. broadened dimensions of silica 
nanoparticles to enhance image contrast and reported a detectable ultrasound behavior after 
administering 100 nm solid silica nanoparticles into mice.41 42 A new class of nanoparticles, 
polymeric nanoparticle has been touted for various biomedical applications due to the 
versatility in modification to incorporate different functionalities.15, 43-45 Nederberg et al. 
synthesized polymeric nanoparticles consisting of cationic amphiphilic triblock 
polycarbonates which selectively lysed microbial membranes.46 They were not only 
biodegradable but also in vivo applicable and highly effective against drug resistant 
bacteria. 
We recently demonstrated that low cytotoxic cationic cobaltocenium 
metallopolymers have antimicrobial efficacy against various bacterial strains including 
multidrug resistant bacteria by disarming activities of β-lactamase.47 These charged 
metallopolymers were capable of protecting conjugated antibiotics via ion-pairing with 
cobaltocenium. We showed that these metallopolymers can inhibit the detrimental effects 
of the β-lactamase enzyme that is responsible for the hydrolysis of β-lactam antibiotics. 
In an effort to further enhance the efficacy of cobaltocenium polymers, herein we 
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report surface-grafted cobaltocenium-containing silica nanoparticles. We carried out 
surface-initiated reversible addition−fragmentation chain transfer (RAFT) polymerization 
of cobaltocenium-containing methacrylate monomer from silica nanoparticles coated with 
4-cyanopentanoic acid dithiobenzoate (CPDB). We then conjugated the antibiotic 
penicillin-G with the nanoparticles by ion-pairing between the cationic cobaltocenium 
moiety in the nanoparticles and carboxylate anions of antibiotics. Such bio-conjugated 
nanoparticles not only reduced the activity of β-lactamase but effectively lysed both Gram-
positive and Gram-negative bacterial cells.  
3.3 Experimental  
Characterization 
1H (400 MHz), 13C (100 MHz), and 19F (376 MHz) NMR spectra were recorded on 
a Varian Mercury 400 NMR spectrometer with tetramethylsilane (TMS) as an internal 
reference. Mass spectrometry was conducted on a Waters Micromass Q-TOF mass 
spectrometer, and the ionization source was positive ion electrospray. UV−vis absorbance 
was carried out on a Shimadzu UV-2450 spectrophotometer with a 10.00 mm quartz 
cuvette and monochromatic light of various wavelengths over a range of 190−900 nm. A 
Hitachi 8000 transmission electron microscope (TEM) was used to acquire images at an 
operating voltage of 150 kV. TEM samples were prepared by dropping a solution of 
nanoparticles on carbon-supported copper grids and then dried before observation. 
Dynamic light scattering (DLS) was operated on a Nano-ZS instrument, Model ZEN 3600 
(Malvern Instruments). Field-Emission Scanning Electron Microscopy (FE-SEM, Zeiss 
UltraPlus) was used for imaging of bacterial cells after overnight incubations with test 
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drugs. The samples were first coated for 45 s with gold using a Denton Dest II Sputter 
Coater, then observed by SEM. 
Materials and Methods 
2-Cobaltoceniumamidoethyl methacrylate hexafluorophosphate (CoAEMAPF6) 
was synthesized according to our earlier report.48 2-Aminoethyl methacrylate 
hydrochloride (90%), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(EDC-HCl, 98%), 4-(dimethylamino) pyridine and tetrabutylammonium chloride (TBACl) 
were purchased from Aldrich and used as received. Water was from Thermo Scientific 
Nanopure with ion conductivity at 18.2 MΩ. The following bacterial strains were 
purchased from ATCC: Staphylococcus aureus (ATCC-33591), Escherichia coli (ATCC-
11775), Klebsiella pneumoniae (ATCC-35596), Proteus vulgaris (P. vulgaris, ATCC-
33420), and Pseudomonas aeruginosa (ATCC-10145). Nitrocefin was purchased from 
TOKU-E and used as received. The sodium salt of penicillin-G was purchased from VWR 
and used as received. 4-Cyanopentanoic acid dithiobenzoate (CPDB) was obtained from 
Strem Chemical Inc. Azobisisobutyronitrile (AIBN) was recrystallized from methanol 
before use. CPDB immobilized silica nanoparticles were synthesized according to the 
literature.49 All other chemicals were from commercial sources and used as received. 
Synthesis of cobaltocenium-containing silica nanoparticles  
CoAEMAPF6 (200 mg, 0.41 mmol) CPDB-coated silica nanoparticles (69.5 mg, 59 
µmol/g, 1 mmol) and 0.4 mL dry dimethyformamide (DMF) were added to a 10 mL 
schlenk tube. To ensure adequate dispersion of silica nanoparticles, the solution was 
sonicated for 5 minutes, and AIBN (0.2 mg, 1.23 µmol) was added. The resulting solution 
was degassed by purging nitrogen for 30 minutes and then placed in an oil bath of 90ᵒC 
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until the desired conversion was met. The polymerization was quenched by opening to air 
and cooling with ice water. The reaction mixture was precipitated in cold dichloromethane 
three times and vacuum-dried. Ion-exchange to Cl– was performed according to a previous 
report using tetrabutylammonium chloride salt (TBACl)50. A typical procedure was as 
follows:1 mL PF6
– paired CsNP (30 mg/mL in acetonitrile) was slowly dropped into 5 mL 
TBACl solution (in acetonitrile) under vigorous stirring. After stirring for 5 minutes, the 
precipitated Cl– paired CsNP was collected and washed by acetonitrile three times to 
remove PF6
– anions and excess TBACl. The solid yellow CsNP-Cl was then vacuum-dried 
and collected. The polymer chains were cleaved using HF, and NMR was done on the 
cleaved polymer chains. 
 
 
Figure 3.1 EDX elemental analysis of homopolymer and nanoparticles  
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Figure 3.2 FT-IR spectrum of nanoparticles 
Synthesis of CsNP-Penicillin bioconjugates  
 
Figure 3.3. 1H NMR spectrum of cobaltocenium-containing nanoparticle-penicillin 
conjugate CsNP in D2O.  
Cobaltocenium-containing silica nanoparticles with Cl– and penicillin-G sodium 
salt were initially dissolved in deionized water (1 mL) with molar ratios (penicillin salt to 
cobaltocenium moieties) in the range of 1.15 to 1.0. The solution was stirred for 2 h and 
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then dialyzed against 3L deionized water for 9 hours. The solution in a dialysis bag was 
collected and freeze-dried. The CsNP-Peni conjugates were obtained as a yellow powder. 
Growth of bacteria 
The antibacterial activity of cobaltocenium-containing silica nanoparticles was 
evaluated using standard disk-diffusion assays (ASTM: the Kirby Bauer diffusion test). 
Firstly, actively-growing cultures of each bacterial strain, previously grown on Mannitol 
salt agar (MSA), were inoculated on Tryptic Soy Broth (TSB) agar plates. A subsample 
(10 μL) of each bacterial culture (cell concentrations were 1.0 × 106 CFU/mL) was diluted 
to 1 mL in TSB, and 100 μL of cell culture was spread on TSB agar plates to form a 
bacterial lawn covering the plate surface. Then a 6 mm filter disc was laid on the agar 
surface, to which the nanoparticle solution was added at the desired concentration. All 
plates were incubated overnight at 37oC. The development of a clear zone around the disk 
was indicative of the ability of antimicrobial drugs to kill bacteria. By quantifying the area 
(knowing its diameter and the depth of the agar) of inhibition, a minimum inhibitory 
concentration (MIC) was calculated for each material/bacterial combination using 
established protocols51. 
Bacterial morphology by FE-SEM. 
Field-emission scanning electron microscopy (FE-SEM) was used to examine 
changes in the morphology of bacterial cells after incubations with test drugs. In summary, 
20 μL of bacterial cell solutions were grown on glass slides in a six-well plate containing 
2 mL TSB medium at 37 oC overnight. Cell suspensions were diluted to OD600 = 1.0. After 
adding predetermined amounts of test drugs to the 1 mL cell stock solution, they were 
incubated overnight at 37 oC. A cell suspension without any chemicals was used as the 
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control. The samples were then fixed in cacodylate buffer with 2.5% glutaraldehyde 
solution (pH = 7.2) for 2–3 h at 4 oC, and post-fixed with 1% osmium tetraoxide at 4 oC 
for 1 h. Samples were dehydrated under critical point, then coated with gold using a Denton 
Dest II Sputter Coater for 120s and observed by FE-SEM.  
LIVE/DEAD bacterial viability assays 
The five bacterial strains were inoculated and prepared by a similar procedure as 
mentioned above. One mL of active bacterial stock solution was introduced to 5 μg 
penicillin solutions. An untreated cell suspension was used as the control. Following 
overnight incubation at 37 oC, 1 μL LIVE/DEAD BacLight (Bacterial Viability Kit; 
Invitrogen Inc.) was added to the incubation solution. After incubation for 15 minutes, cells 
were imaged using a Leica TCS SP5 Laser Scanning Confocal Microscope with 63X oil 
immersion lens. When excited at 488 nm with Argon and Helium/Neon lasers, bacteria 
with intact membranes display green fluorescence (Emission = 500 nm) and bacteria with 
disrupted membranes fluoresced red (Emission = 635 nm). 
Drug Resistance Study 
At first 50 μL aqueous solution of CsNP-penicillin conjugates with 0.5 x the MIC 
concentration were added to 96-well plates. Then, 150 μL bacterial TSB solution (OD600 = 
1.00) were added to the wells. The bacterial TSB solution without conjugates was used as 
the control. The assay plate was incubated at 37oC until the bacteria were grown to an 
optical density of about 1.00 (OD600 = ~ 1.00) in control samples. All assays were carried 
out in duplicate in the same assay plate. The experiment was repeated for 15 passages.  
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Effects of CsNP copolymers on β-lactamase activity  
50 μL nitrocefin (DMSO solution 1.0 μg/mL) and CsNP with different 
concentrations (100, 200 and 400 μg) were added into 1 mL H2O and stirred for 12 h.  Then, 
1 μL β-lactamase PBS buffer solution (0.1 μg/mL, determined by Bio-rad Protein Assay) 
was added to the above solution. A solution without nanoparticles was used as a control. 
After 1 h, the β-lactamase activity was measured by UV-vis absorbance at 480 nm. 
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Figure 3.4. (a) Optical view of nitrocefin solution with different amounts of CsNP after 
adding β-lactamase for 1 h; and (b) UV−vis absorption. 
 
Hemolysis evaluation for cytotoxicity determination 
Blood was collected from mice in heparinized tubes and diluted by mixing 800 µL 
blood with 1000 µL PBS. Nanoparticle samples were prepared in PBS at concentrations 
10, 50, 100 and 500 µg/mL and added 60 µL of the diluted blood samples to 3 mL of the 
nanoparticle conjugates, PBS or 0.1% Triton-X100 in PBS. The samples were incubated 
for 1 h at 37°C followed by centrifugation for 10 minutes at 1500 rpm. Supernatants were 
collected and OD was measured at 545 nm to calculate Hemolysis rate by using the 
formulae, HR=(AS-AN)/(AP-AN) where AS, AN and AP are OD values of the 
supernatants from test samples, negative control (PBS) and positive control (0.1% Triton-
X100) respectively. 
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Figure 3.5. Hemolysis test results for CsNP-penicillin conjugate. 
3.4 Results and Discussion 
Synthesis of Cobaltocenium-Containing Silica Nanoparticles 
The cobaltocenium-containing silica nanoparticles (CsNP) were prepared via 
RAFT polymerization using 2-cobaltocenium amidoethyl methacrylate 
hexafluorophosphate (CoAEMAPF6) as a monomer, AIBN as an initiator, mediated by 
CPDB-coated silica nanoparticles in DMF at 90 ᵒC (Scheme 3.1). We previously 
synthesized a cobaltocenium methacrylate monomer with ester and amide linkers for 
various applications and studies.52-54,27 A similar procedure was followed to synthesize 
CoAEMAPF6 by reacting cobaltocenium monoacid with 2-aminoethyl methacrylate 
hydrochloride in the presence of a coupling agent N-(3-di-methylaminopropyl)-N’-
ethylcarbodiimide (EDC).  
 
 
 
 
49 
Scheme 3.1 Synthesis of cobaltocenium-containing silica nanoparticles by surface-
initiated RAFT polymerization. 
 
RAFT polymerization has been demonstrated to provide quantitative and precise 
control over the molecular weight.55-57 We carried out RAFT polymerization by exploiting 
a “grafting from” technique.49, 58-60 The silane surface chemistry was used to treat the 
colloidal silica nanoparticles with 3-aminopropyldimethylethoxysilane followed by the n 
amidation reaction between amino groups and CPDB RAFT agent. The amount of RAFT 
agent anchored onto the modified silica nanoparticles was determined quantitatively by 
comparing the absorption at about 303 nm for the CPDP anchored silica nanoparticles to a 
standard absorption curve made from known amounts of the free CPDB. Three different 
types of silica nanoparticles were synthesized by differing various grafting densities from 
0.084 chain/nm2 to 0.481 chain/nm2 (20 µmol/g, 59 µmol/g and 114 µmol/g CPDB). These 
grafting densities were all significantly under the maximum grafting density of CPDB 
(~0.7 chain/nm2). The disappearance of the vinyl protons from methacrylate around 6.2 
and 5.6 ppm and appearance of broad peaks around 0.5-2.0 ppm in the 1H NMR spectrum 
suggested the successful polymerization (Figure 3.3). The molecular weight was controlled 
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by tracking the conversion during the polymerization process using NMR. The polymers 
were obtained with the degree of polymerization in the range of 26-28. The targeted 
molecular weight was in the range of 12,000-15,000 g/mol, which displayed strong 
antibacterial properties based on our previous studies (Table 3.1).47 The nanoparticles were 
further characterized by FTIR and EDX elemental analysis to confirm the presence of 
major bonds and elements in the nanoparticles respectively (Figure 3.1 and Figure 3.2).  
Table 3.1 Cobaltocenium-containing silica nanoparticles and their characterization. 
Entry Total surface 
densitya 
 (µmol/g) 
Total surface 
density 
(chain/nm2) 
Mn b 
(g/mol) 
Diameter c 
(nm) 
Zeta 
potential d 
(mV) 
CsNP 1 20 0.084 12,700 48 40.4 
CsNP 2 59 0.249 13,700 50 55.1 
CsNP 3 114 0.481 13,200 51 62.6 
a Equivalent of CPDB; b Mn calculated by conversion of CoAEMAPF6 via NMR; c 
Diameter calculated via DLS; d Zeta potential calculated via DLS 
 
A facile phase-transfer ion-exchange method has been established to prepare 
hydrophilic cationic cobaltocenium-containing polyelectrolytes with diverse counterions 
using tetra-butylammonium chloride (TBACl) salts.50 Thus nanoparticles with PF6– anions 
were subjected to anion exchange with TBACl to result in hydrophilic chloride-based 
particles. The complete conversion from PF6–  to Cl– was confirmed by running 19F NMR 
of resultant nanoparticles. The switch of anions to chloride significantly increased the 
hydrophilicity of the nanoparticles and facilitated the use of these particles for biomedical 
applications. The strong electrostatic interaction between the cationic cobaltocenium 
moieties and stationary phase of microstyragel columns made it impossible to observe use 
gel permeation chromatography (GPC). The nanoparticles were further conjugated with 
penicillin based on the ionic interaction between anionic penicillin sodium salt and cationic 
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cobaltocenium moiety, resulting in penicillin-conjugated cobaltocenium-containing silica 
nanoparticles (CsNP). The excess penicillin salt, which was not complexed with 
nanoparticles, was removed by dialysis. For the convenience, the nanoparticle conjugates 
were referred to as CsNP 1(20 µmol/g), CsNP 2 (59 µmol/g) and CsNP 3 (114 µmol/g) 
hereafter. 
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Figure 3.6. a) Dynamic Light Scattering measurements showing sizes of nanoparticles; and 
b) Thermogravimetric analysis of cobaltocenium-containing silica nanoparticles.  
The mean diameter of cobaltocenium-containing nanoparticles was found to in the 
range of 40-50 nm, as measured by dynamic light scattering (Figure 3.5a). The diameter of 
bare silica nanoparticles was around 20-25 nm, and after polymerization the mean diameter 
increased as expected. The diameter of individual cobaltocenium-containing nanoparticles 
from TEM images (Figure 3.7) were consistent with DLS results. Thermogravimetric 
analyses (TGA) showed accurate weight loss of nanoparticles with different grafting 
densities (Figure 3.6b). To determine the weight percentage of the cobaltocenium, TGA of 
homopolymers and bare silica nanoparticles were compared with that of cobaltocenium-
grafted nanoparticles. Based on the TGA measurements, the total weight percentage of 
cobaltocenium in the nanoparticle in CsNP ranged from 56 wt% to 65 wt%. This 
information together with 1H NMR allowed us to calculate the weight percentage of 
 
 
52 
penicillin in the nanoparticles, which was in the range of 28-35 wt%.  The equimolar 
pairing of penicillin with cobaltocenium was confirmed by 1H NMR by calculating the 
integration ratio of aromatic peaks ~7.2 ppm from penicillin to the cyclopentadienyl peaks 
of polymers ~ 5.5-6.1 ppm (Figure 3.3). 
 
Figure 3.7 TEM images of nanoparticles: a) CsNP 1; b) CsNP 2; c) CsNP 3. 
Antimicrobial Activity of Cobaltocenium-Containing Silica Nanoparticles 
Antimicrobial susceptibility was determined by the conventional agar disk-
diffusion assay following a protocol of Kirby Bauer diffusion test.61  Staphylococcus 
aureus and Escherichia coli were chosen as representative Gram-positive and Gram-
negative bacteria, respectively. To find the effective optimal concentration, three different 
amounts of penicillin (4µg, 6µg and 8 µg) were tested against the two bacterial strains.  
While carrying out the disk diffusion assays, concentrations of penicillin were kept 
constant in both nanoparticle treatments and controls. The optimal activity was obtained 
with 6 µg penicillin and used throughout the tests. The ability of the complex to kill the 
bacteria was represented by the development of a clear zone around the disk, also known 
as the inhibition zone. Higher inhibition zones were seen in case of the Gram-positive S. 
aureus in comparison to the Gram-negative E. coli. The additional outer polysaccharide 
layer in the Gram-negative bacteria might have acted as an extra layer of shielding for the 
test drugs to penetrate, resulting in the smaller inhibition zone.61  
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For further investigations of Gram-negative bacteria, tests were extended to the 
following bacteria using the above-mentioned protocol: Pseudomonas aeruginosa, Proteus 
vulgaris, and Klebsiella pneumonia.  Among them, P. aeruginosa, K. pneumonia and S. 
aureus are among the six pathogens in a class “ESKAPE” termed by CDC, which can evade 
the influence of antibiotics and develop resistance.62  As shown in Figure 3.8, penicillin-G 
alone showed minimal antibacterial efficacy at a given concentration, when compared to 
the CsNP bioconjugates. In case of S. aureus, the inhibition zone caused by penicillin was 
9 mm while the zones created by CsNP-penicillin conjugates were much larger: approx. 19 
mm. The amount of cobaltocenium in the control CsNP-Cl was probably too low for 
observing the onset of any antimicrobial activity. The inhibition zone caused by 
homopolymer conjugate (PCo-Peni) was 12 mm, which was larger than the penicillin 
alone, but still smaller than those observed for nanoparticle-penicillin conjugates. All three 
CsNP-penicillin conjugates resulted in bigger inhibition zones than penicillin, CsNP-Cl 
nanoparticles and the homopolymer-penicillin conjugate. 
The results demonstrated the synergistic effects of the cobaltocenium-penicillin 
complex in protecting the antibiotics leading to increased lysis of bacterial cells. This led 
us to believe that CsNP-penicillin conjugates could be an upgraded ammunition from the 
currently known homopolymer-penicillin conjugate in combating bacterial infections.  
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Figure 3.8 Inhibition zones of CsNP-Peni conjugates against various strains of bacteria at 
6 μg penicillin-G/disk using disk-diffusion assays: a) S. aureus; b) E. coli; c) P. vulgaris; 
d) K. pneumonia; e) P. aeruginosa. 
The CsNP conjugates have a greater charge density of cationic cobaltocenium on 
the surface, which provides an advantage for higher bactericidal efficacy when compared 
to the individual polymers. Even though the grafting densities of the nanoparticles were 
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different, the inhibition zones caused by the nanoparticle conjugates were similar. This 
could be attributed to the similar sizes of nanoparticle conjugates resulting in a similar zone 
of diffusion in the Agar gel.  The diameters of nanoparticles were very close to each other; 
thus, we predict that similar zones of nanoparticle diffusion likely occurred in the agar gel 
leading to the observed similar antimicrobial activities.  
Table 3.2 Minimum inhibitory concentrations (MICs) of different agents against five 
strains of bacteria. 
Compounds Minimum Inhibitory Concentration (MIC, µg/mL) 
 S. aureus E. coli P. vulgaris P. 
aeruginosa 
K. 
pneumonia 
CsNP 1 3.03 5.57 5.42 5.57 10.92 
CsNP 2 3.78 7.58 5.91 6.46 9.90 
CsNP 3 2.73 4.85 5.20 5.57 10.10 
Penicillin 13.48 17.06 17.50 19.41 26.66 
   
Minimum inhibitory concentrations were calculated for each material/bacterial 
combination using established protocol and are given in Table 3.2.51 The mean MIC of 
CsNPs against Gram-positive strain S. aureus was 3.18 +0.54 µg/mL, which was 
approximately four times lower than that of penicillin, 13.48 µg/mL. Similarly, for Gram-
negative strains, the MIC values of CsNPs followed a similar trend and much lower than 
the penicillin alone. Compared with penicillin alone, nanoparticle-polymer conjugates 
produced significantly higher efficacies against both Gram-positive and Gram-negative 
strains. 
The increased bactericidal effectiveness was further supported by qualitative 
observations using confocal scanning laser microscopy (CSLM) studies (Figure 3.9). 
LIVE/DEAD bacteria viability assays using CSLM indicated greater levels of cell death 
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and lower cell densities when bacterial cells were exposed to CsNP-Peni conjugates. Most 
of the cells exposed to penicillin alone were exhibited primarily green fluorescence 
indicating live cells, while cells incubated with CsNP-Peni bioconjugates displayed 
primarily red or yellow fluorescence, indicating cell death. 
 
Figure 3.9 Confocal scanning laser microscopy images of control, penicillin and CsNP-
penicillin conjugates with a concentration of penicillin 6 μg/mL (using BacLight live/dead 
stain, green indicates live cells, red indicates dead cells) against E. coli and S. aureus. The 
bacterial solution without CsNPs was used as the control. 
Also, the SEM imaging was used to compare differences in morphology before- 
and after-treatment with CsNP-Peni conjugates (Figure 3.10). Control samples contained 
intact bacterial cells with smooth surfaces while the cells incubated with conjugates were 
significantly damaged with obvious disruptions in the original morphology. The collapsed 
cell envelopes of the incubated bacterial cells marked the physical damage of cell 
membranes. 
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Figure 3.10 Scanning electron microscopy (SEM) images of control and CsNP-penicillin 
conjugates with a concentration of penicillin at 6 μg/mL against E. coli and S. aureus. 
Bacterial solutions without CsNPs were used as the control. 
The nitrocefin assay, in conjunction with UV-Vis spectrophotometry, was used to 
observe the effects of CsNP on β-lactamase activity (Figure 3.4). The original yellow color 
of controls of a nitrocefin solution, changed to red within a few minutes after the addition 
of β-lactamase. The change in color was the result of hydrolysis of β-lactam ring of 
antibiotics, and can be observed by an absorption peak near 480 nm (Figure 3.4b).63 When 
nitrocefin was complexed with CsNP, there was a minimal change in color implying the 
protection of β-lactam ring by the cobaltocenium moiety complex. When a higher 
concentration of CsNP was used, the color of the yellow solution remained unchanged. 
This was interpreted as the complete shutdown of β-lactamase activity against β-lactam 
antibiotics.  
To evaluate the probability of the CsNP-penicillin conjugates to induce resistance 
in bacteria, drug resistance study was conducted for the most potent nanoparticle conjugate, 
CsNP 3 (lowest MIC) against both Gram-positive and Gram-negative bacteria. As shown 
in Figure 3.11, the OD600 values of the nanoparticle conjugates remain virtually constant 
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even after 15 consecutive passages against both S. aureus and E. coli, indicating that the 
bacteria did not develop resistance readily toward the nanoparticle conjugate.  
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Figure 3.11 Drug resistance study of CsNP-penicillin conjugates against various bacteria. 
The improved bactericidal efficiencies of CsNP-penicillin conjugates could be 
attributed to the enhanced local concentration of cobaltocenium-penicillin complex on the 
nanoparticle surface. Most of the antibacterial agents administered in the body to combat 
microbial infections diffuse to cell membranes once solubilized. This process could result 
in a lower concentration of antibacterial compounds a given bacterial cell receives, and 
thus could be less effective. In contrast, we increased the concentration of the 
cobaltocenium-penicillin conjugates on the surface, which supplied an enhanced dose to 
overwhelm the bacterial cell, resulting in effective lysis. In addition, the larger surface area 
of the nanoparticle could provide more active sites to contact the bacteria resulting in more 
bacterial death. In order to determine the toxicity of the CsNPs, we analyzed the 
cytotoxicity of CsNP 3 on red blood cells (RBCs) by evaluating whether they could lead 
to hemolysis of RBCs. We found that even at a concentration as high as 500 µg/mL, 
extremely low (< 5%) percentages of cells were lysed by CsNP 3 compared to the negative 
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control group as shown in Figure 3.5. This implies that the CsNPs do not cause significant 
toxicity and hence could be safe in the host. 
3.5 Conclusions 
In summary, we engineered the surfaces of silica nanoparticles with cobaltocenium 
polymers, having varied grafting densities using RAFT polymerization. These 
nanoparticles were then loaded with the β-lactam antibiotic penicillin-G, based on 
electrostatic interaction between cationic cobaltocenium moiety and anionic antibiotic. The 
resulting conjugates showed vastly improved bactericidal efficiencies against both Gram-
positive and Gram-negative bacterial pathogen strain, and facilitated the revitalization of 
the β-lactam drug, penicillin. The nanoparticle-drug complex resisted hydrolysis by β-
lactamase, the enzymatic mechanism used by many bacteria to resist β-lactam drugs. Not 
only did the complex rejuvenate bactericidal efficacy, but also provided an enhanced local 
dose of the penicillin and overwhelmed the bacterial cells, proving to be a more effective 
antimicrobial agent. This design has enabled us to achieve a promising new paradigm to 
improve the vitality of conventional antibiotics, with strong bactericidal effects and 
minimal cytotoxicity to host human cells. 
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CHAPTER 4 
RECYCLABLE MAGNETIC NANOPARTICLES GRAFTED WITH 
ANTIMICROBIAL METALLOPOLYMER-ANTIBIOTIC BIOCONJUGATES3
                                                          
3 Pageni, P.; Yang P.; Bam M.; Zhu T.; Chen Y. P.; Decho A. W.; Nagarkatti M.; Tang, C. 
Recyclable Magnetic Nanoparticles Grafted with Antimicrobial Metallopolymer-
Antibiotic Bioconjugates Biomaterials, 2018, In press. Reprinted here with permission of 
publisher. 
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4.1 Abstract 
Over-prescription and improper use of antibiotics has led to the emergence of 
bacterial resistance and now poses a major threat to public health. There has been 
significant interest in the development of alternative therapies and agents to combat 
antibiotic resistance. We report the preparation of recyclable magnetic iron oxide 
nanoparticles grafted with charged cobaltocenium-containing metallopolymers by surface-
initiated reversible addition-fragmentation chain transfer (RAFT) polymerization. β-
Lactam antibiotics were then conjugated with metallopolymers to enhance their vitality 
against both Gram-positive and Gram-negative bacteria. The enhanced antibacterial 
activity was a result of synergy of antimicrobial segments that facilitate the inhibition of 
hydrolysis of antibiotics and local enhancement of antibiotic concentration on a 
nanoparticle surface. These magnetic nanoparticles can be recycled numerous times 
without losing the initial antimicrobial potency.  Studies suggested negligible toxicity of 
metallopolymer-grafted nanoparticles to red blood cells and minimal tendency to induce 
resistance in bacteria. 
4.2 Introduction 
The emergence of antibiotic resistance is not only a threat to global health but also to 
the economy. Antibiotic resistance infections result in increased mortality and excess costs 
in both clinical and community settings.  According to a report by CDC, it is now predicted 
that global mortality by bacterial infection would reach 10 million annually by the year 
2050 and cost an estimated $100 trillion dollars in lost economic output[1]. As a result of 
excessive use, traditional antibiotics exhibit a rapidly decreased efficacy. In some cases, 
infections become untreatable and more patients succumb from other conditions such as 
AIDS, whose etiology is complicated by antibiotic resistance infections[2]. This threatens 
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many of the most significant medical advances that have been made, and results in 
increasing therapeutic costs and extended hospitalization. The antibiotics have lost their 
efficacy gradually as a result of emergence and circulation of antibiotic resistance among 
bacteria. Inspired by antimicrobial peptides, synthetic polymers containing cationic groups 
like quaternary ammonium or sulfonium have been studied extensively and almost 
exclusively as a measure to fight back bacterial resistance due to the physical nature of 
their action of damage to the membranes[3-11]. However, the less selective mode of action 
of these polymers results in toxicity towards mammalian cells, and thus the quest persists 
for safer, more-effective antimicrobial agents. 
Nanomaterials have been gaining much attention as antimicrobials that are 
complementary to antibiotics, and fill important gaps where antibiotics often fail[12]. The 
diversity of nanoparticles that are currently in use ranges from metal, metal oxides to 
organic forms. Nanoparticles can be engineered with high specificity to produce surfaces 
having different types of functional groups, charges and other properties. Magnetic 
nanoparticles have been an area of interest for researchers from a wide range of disciplines 
including catalysis[13, 14], data storage[15, 16], environmental remediation[17], magnetic 
resonance imaging[18] and biomedicines[19-22]. In particular, a wide variety of 
biomedical applications range from contrast agents for magnetic resonance imaging to the 
deterioration of cancer cells via hyperthermic treatment[23]. 
Specifically, iron oxide particles, with size ranges of nanometer scale, display 
superparamagnetic properties and could interact magnetically with each other when not 
properly stabilized. Due to their extremely large surface-to-volume ratio and the large 
surface energy, magnetic nanoparticles tend to aggregate. In addition, naked metallic 
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nanoparticles have a high chemical activity and are prone to oxidation in air resulting in 
loss of magnetism and dispersibility[24]. To circumvent these problems, it is essential to 
protect and stabilize the naked magnetic nanoparticles by using either ionic compounds or 
large molecules such as polymers or surfactants containing long hydrocarbon chains.  
Polymer grafting has become a popular technique for tuning the surface properties of 
nanoparticles[25-29]. Also, magnetic nanoparticles without polymer coatings often 
aggregate in water or tissue fluid, which may limit their applications. Grafting of polymers 
not only stabilizes the nanoparticles but also opens the door for further functionalization. 
Antibiotics have been the major therapy to treat various kinds of bacterial infections 
for nearly a century. However, there is hardly any class of antibiotics that has escaped the 
resistance mechanism by bacteria. The time interval between the launch of a new antibiotic 
in clinical practice and the emergence of resistance has been variable and rapidly 
shortening over the past century[30]. The strategy of discovering and developing new 
antibiotics is necessary but may not address the concern of bacterial resistance for long. 
The approach to breathe life into traditional antibiotics and antimicrobial agents using new 
therapeutic approaches to treat infection-associated diseases seems fruitful and addresses 
the urgent need and provides economic incentives. 
We postulated that linking antimicrobial agents to nanoparticles may represent a 
powerful, yet adaptable tool to more-efficiently limit antibiotic-resistant infections. We 
recently developed a class of charged cobaltocenium-containing metallopolymers with 
minimal toxicity and good antimicrobial efficacy[31-33]. These metallopolymers not only 
kill the bacteria but also protect β-lactam antibiotics from the detrimental hydrolysis of β-
lactamase enzyme.  
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Scheme 4.1. Synthesis of cobaltocenium-containing silica nanoparticles by surface-
initiated RAFT polymerization. 
 
Herein we report new work on grafting cobaltocenium-containing polymers from iron 
oxide nanoparticles using surface-initiated reversible addition-fragmentation chain transfer 
(SI-RAFT) polymerization (Scheme 4.1). In doing so, the magnetic properties of 
nanoparticles compliment the antimicrobial features of cobaltocenium-containing 
polymers, and result in a new class of materials having highly-applicable characteristics 
such as magnetic antimicrobial nanoparticles that can impact therapies to tackle rampant 
bacterial infections. These nanoparticles were then conjugated with β-lactam antibiotics, 
such as penicillin, via ion-pairing between the cationic cobaltocenium moiety in the 
nanoparticles and the carboxylate anion of antibiotics. The newly-synthesized nanoparticle 
conjugates displayed significantly enhanced antimicrobial efficacy against both Gram-
positive and Gram-negative strains. In addition, they can be recycled for at least 15 
passages without losing the potency. 
4.3 EXPERIMENTAL SECTION 
Characterization 
1H (400 MHz), 13C (100 MHz), and 19F (376 MHz) NMR spectra were recorded on 
a Varian Mercury 400 NMR spectrometer with tetramethylsilane (TMS) as an internal 
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reference. Mass spectrometry was conducted on a Waters Micromass Q-TOF mass 
spectrometer, and the ionization source was positive ion electrospray. UV−vis was carried 
out on a Shimadzu UV-2450 spectrophotometer with a 10.00 mm quartz cuvette and 
monochromatic light of various wavelengths over a range of 190−900 nm. A Hitachi 8000 
transmission electron microscope (TEM) was applied to take images at an operating 
voltage of 150 kV. TEM samples were prepared by dropping solution on carbon-supported 
copper grids and then dried before observation. Dynamic light scattering (DLS) was 
operated on a Nano-ZS instrument, model ZEN 3600 (Malvern Instruments). Field-
Emission Scanning Electron Microscopy (FE-SEM, Zeiss UltraPlus) was used to take 
images of bacterial cells after incubating overnight with test drugs. The samples were 
coated with gold using Denton Dest II Sputter Coater for 45 s and then observed by SEM. 
Materials and Methods 
2-Cobaltoceniumamidoethyl methacrylate hexafluorophosphate (CoAEMAPF6) 
was synthesized according to our earlier reports[52, 56]. 2-Aminoethyl methacrylate 
hydrochloride (90%), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(EDC-HCl, 98%), 4-(dimethylamino) pyridine and tetrabutylammonium chloride (TBACl) 
were purchased from Aldrich and used as received. Water was from Thermo Scientific 
Nanopure with ion conductivity at 18.2 MΩ. The following bacterial strains were 
purchased from ATCC: Staphylococcus aureus (S. aureus, ATCC-33591), Bacillus cereus 
(B. cereus, ATCC 11778), Escherichia coli (E. coli, ATCC-11775), Klebsiella pneumoniae 
(K. pneumoniae, ATCC-35596), Proteus vulgaris (P. vulgaris ATCC 33420). Nitrocefin 
was purchased from TOKU-E and used as received. Sodium salt of penicillin-G was 
purchased from VWR and used as received. 4-Cyanopentanoic acid dithiobenzoate 
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(CPDB) was obtained from Strem Chemical Inc. Azobisisobutyronitrile (AIBN) was 
recrystallized from methanol before use. All other chemicals and reagents were from 
commercial sources and used as received. 
Synthesis of iron oxide nanoparticles  
The iron oxide nanoparticles were prepared by a co-precipitation method using a 
mixture of two salts (FeCl2 and FeCl3)[57]. Briefly, 0.01 mol FeCl2.4H2O and 0.02 mol 
FeCl3.6H2O were dissolved in 100 mL of deionized and deoxygenated water. Then, 0.08 
mol of NaOH in 100 mL was added dropwise for 3 hours under nitrogen using a Soxhlet 
funnel while stirring. The precipitate was washed with water/ethanol repeatedly and dried 
in a desiccator for 24 hours. The RAFT agent was anchored in the nanoparticles following 
a reported procedure[44]. In short, Iron oxide nanoparticles (0.5 g) was dispersed in dry 
THF and 3-aminopropyldimethylethoxysilane (0.32 mL, 1 mmol) was added. The mixture 
was refluxed in an oil bath for 6 h under nitrogen protection. After cooling to room 
temperature, the reaction was precipitated in 250 mL hexanes. The particles were 
precipitated three times and each time they were easily recovered by centrifugation. For 
the next part, 0.2 g, (0.4 mmol) of activated 4-cyano-4-
(phenylcarbonylthioylthio)pentanoate (CPDB) was added dropwise to the dispersed 
solution of iron oxide nanoparticles in THF at room temperature. The solution was stirred 
overnight and precipitated in hexanes. The CPDB-anchored nanoparticles were recovered 
by centrifugation and dried in vacuum. The particles were then dispersed in THF and stored 
for later use. 
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Synthesis of cobaltocenium-containing iron oxide nanoparticles  
CoAEMAPF6 (200 mg, 0.41 mmol), CPDB-coated iron oxide nanoparticles (245 
mg, 1 mmol) and 0.4 mL dry dimethyformamide (DMF) were added to a 10 mL Schlenk 
tube. To ensure good dispersion of nanoparticles, the solution was sonicated for 5 minutes, 
and AIBN (0.2 mg, 1.23 µmol) was added. The resulting solution was degassed by purging 
nitrogen for 30 minutes and then placed in an oil bath of 90 ᵒC until the desired conversion 
was met. The polymerization was quenched by opening to air and cooling with ice water. 
The reaction mixture was precipitated in cold dichloromethane three times and vacuum-
dried. Ion-exchange of Cl– was performed according to a previous report using 
tetrabutylammonium chloride salt (TBACl) [53]. A typical procedure was as follows:1 mL 
PF6
– paired FeNP (30 mg/mL in acetonitrile) was slowly dropped into 5 mL TBACl 
solution (in acetonitrile) under vigorous stirring. After stirring for 5 minutes, the 
precipitated Cl– paired FeNP was collected and washed by acetonitrile three times to 
remove PF6
– anions and excess TBACl. The solid yellow FeNP-Cl was then vacuum-dried 
and collected. 
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Figure 4.1 EDX elemental analysis of cobaltocenium-containing iron oxide nanoparticles 
and cobaltocenium-containing homopolymer.  
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Synthesis of FeNP-Penicillin bioconjugates  
Cobaltocenium-containing iron oxide nanoparticles with Cl– was initially dispersed 
in deionized water and solution of penicillin-G sodium salt was added slowly with molar 
ratios (penicillin salt to cobaltocenium moieties) in the range of 1.15 to 1.0. The solution 
was stirred for 2 h and then dialyzed against 3L deionized water for 9 hours. The solution 
in a dialysis bag was collected and freeze-dried. The FeNP-Pen conjugates were obtained 
as a yellow powder. 
Growth of bacteria 
The antibacterial activity of cobaltocenium-containing iron oxide nanoparticles was 
evaluated using standard disk-diffusion assay (ASTM: the Kirby Bauer diffusion test)[55]. 
Firstly, actively-growing cultures of each bacterial strain on Mannitol salt agar (MSA) were 
inoculated on Tryptic Soy Broth (TSB) agar plates. The bacterial growth culture (cell 
concentrations were 1.0 × 106 CFU/mL) 10 μL was diluted to 1 mL in TSB, and 100 μL of 
cell culture was spread on TSB agar plates to form a bacterial lawn covering the plate 
surface. Then a 6 mm filter disc was laid on the agar surface, to which the nanoparticle 
solution was added at a desired concentration. All plates were incubated overnight at 37oC. 
Bacterial morphology by FE-SEM. 
Field-emission scanning electron microscopy (FE-SEM) was used to examine the 
morphology of bacterial cells after incubating with test drugs. In summary, 20 μL of 
bacterial cell solution was grown on one glass slide in a six-well plate containing 2 mL 
TSB medium at 37 oC overnight. Cell suspensions were diluted with OD600 = 1.0. After 
adding calculated amount of test drugs to the 1 mL cell stock solution, it was left to incubate 
overnight at 37 oC. A cell suspension without added chemicals was used as the control. 
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The samples were then fixed in cacodylate buffered with 2.5% glutaraldehyde solution (pH 
= 7.2) for 2–3 h at 4 oC and post-fixed with 1% osmium tetroxide at 4 oC for 1 h. Samples 
were dehydrated under critical point, then coated with gold using Denton Dest II Sputter 
Coater for 120s and observed by FE-SEM.  
LIVE/DEAD bacterial viability assays 
The five bacterial strains were inoculated and prepared by a similar procedure as 
mentioned above. 1 mL of active bacterial stock solution was introduced to 5 μg penicillin 
solutions. An untreated cell suspension was used as the control. Following overnight 
incubation at 37oC, 1 μL LIVE/DEAD BacLight (Bacterial Viability Kit; Invitrogen Inc.) 
was added to the incubation solution. After incubation for 15 minutes, cells were imaged 
using a Leica TCS SP5 Confocal Scanning Laser Microscope with 63X oil-immersion lens. 
Stained cells were excited at 488 nm with a Krypton-Argon laser. Bacteria cells having 
intact membranes display green fluorescence (Emission = 515 nm) and bacteria with 
disrupted membranes fluoresce red (Emission = 635 nm). 
Drug Resistance Study 
50 μL aqueous solution of FeNP-penicillin conjugates with one-half the MIC 
concentration were added to 96-well plates. Then, 150 μL bacterial TSB solution (OD600 = 
1.00) were added to the wells. The bacterial TSB solution without conjugates was used as 
the control. The assay plate was incubated at 37oC until the bacteria were grown to an 
optical density of about 1.00 (OD600 = ~ 1.00) in control samples. All assays were carried 
out in duplicate in the same assay plate. The process was repeated every 20-22h for up to 
15 passages.  
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Recycling of FeNP-Pen for antibacterial assays 
5 μl bacterial suspensions were inoculated into 3 mL TSB solutions at 37 °C for 
incubation at 300 rpm overnight. Identical bacterial culture solutions were prepared in three 
different tubes. The first tube was used as the control without adding any test samples while 
the second tube was used to determine the activity of penicillin. 2 × MIC of nanoparticle 
conjugates was added to the third tube before incubation. Bacterial growth was measured 
at OD600, and was compared with the control tube. The inhibition efficiency was calculated 
as follows: inhibition efficiency (%) = (Control OD600 - Sample OD600)/ Control OD600 × 
100. The control OD600 was determined from the blank tube.  
     
Figure 4.2 Images of cobaltocenium-containing iron oxide nanoparticles incubating and 
recycling against various bacteria  
Each test was conducted in duplicate. After incubating overnight, the tube was 
placed adjacent to a magnet stand at room temperature for 10 min. The nanoparticles were 
attracted to the wall of the tube via magnetic force. After removing the supernatant from 
the tube, penicillin was added to complex with the nanoparticle. Any remaining penicillin 
was removed by washing with aqueous solution. The test was then repeated for total of 5 
passages. 
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Time-kill Study 
 The kinetics of antibacterial activity of nanoparticle conjugate was investigated. In 
summary, various concentrations of the nanoparticle conjugate were incubated at a time 
interval of 1 h, 2 h, 4 h, 6 h, 8 h and 12 h. During each interval, 100 µL of the culture 
solution was taken and diluted to 106 times. The final diluted solution was spread on agar 
plates to incubate at 37ᵒC overnight and the colonies were counted next day. The 
experiment was carried out in duplicate. 
Hemolysis evaluation for cytotoxicity determination. 
Blood was collected from mice in heparinized tubes and diluted by mixing 800 µL 
blood with 1000 µL PBS. Nanoparticle samples were prepared in PBS at concentrations 
10, 50, 100 and 500 µg/mL and added 60 µL of the diluted blood samples to 3 mL of the 
nanoparticle conjugates, PBS or 0.1% Triton-X100 in PBS. The samples were incubated 
for 1 h at 37°C followed by centrifugation for 10 minutes at 1500 rpm. Supernatants were 
collected and OD was measured at 545 nm to calculate Hemolysis rate by using the 
formulae, HR=(AS-AN)/(AP-AN) where AS, AN and AP are OD values of the 
supernatants from test samples, negative control (PBS) and positive control (0.1% Triton-
X100) respectively. 
 
 
76 
 
Figure 4.3 Hemolysis test results for FeNP nanoparticles. 
4.4 Results and Discussion 
Synthesis of Cobaltocenium-Containing Iron Oxide Nanoparticles 
We introduced cationic cobaltocenium along with antibiotics onto iron oxide 
nanoparticles to form magnetic antimicrobial nanoparticles, as shown in Scheme 4.2. To 
be specific, cobaltocenium-containing polymers were grafted from iron oxide 
nanoparticles, which were then installed with penicillin via ionic complexation. 
Cobaltocenium, a cationic and high-oxidation state metallocene, has recently gathered a lot 
of attention for its various applications derived from its excellent chemical stability and 
superior binding ability to anions[34-42]. The pathway for the synthesis of magnetic 
nanoparticles consisted of the formation of iron oxide nanoparticles by coprecipitation of 
Fe2+ and Fe3+ salts in the presence of an alkaline solution followed by the immobilization 
of RAFT agent on to the nanoparticle surface. The commonly-used coprecipitation method 
was chosen because of its simplicity, low cost and high efficiency [43]. The surface of 
nanoparticles was further functionalized with 3-aminopropyldimethylethoxysilane 
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followed by an amidation reaction between its amino group and acid group of an RAFT 
agent, 4-cyanopentanoic acid dithiobenzoate (CPDB)[44]. The amount of RAFT agent 
anchored onto the modified iron oxide nanoparticles was quantitatively determined by 
comparing the absorption for CPDB from iron oxide nanoparticles to free CPDB. The 
grafting density was found to be 0.15 chain/nm2 (16.5 µmol/g CPDB). 
In conjunction with well-developed controlled radical polymerization techniques, 
especially RAFT, the “grafting from” strategy provides an efficient route to functionalize 
surface by controlling compositions and structures[45-49]. RAFT polymerization provides 
quantitative and precise control over the molecular weight[50, 51]. The next step was 
mediated by CPDB-coated iron oxide nanoparticles to carry out polymerization of a 
monomer, 2-cobaltocenium amidoethyl methacrylate hexaflurophosphate (CoAEMAPF6), 
using AIBN as an initiator in dry DMF at 90 ᵒC, as shown in Scheme 4.2. CoAEMAPF6 
was synthesized using a previously established procedure[52]. Cobaltocenium-containing 
polyelectrolytes with hydrophobic anions can be easily switched to hydrophilic ones using 
tetra-butylammonium salts via a facile phase-transfer ion-exchange method[53]. In this 
case, the nanoparticles with PF6¯ anions were subjected to ion exchange, which resulted in 
hydrophilic chloride-paired nanoparticles. The newly formed nanoparticles had good 
aqueous solubility, which opened the door for use in biomedicines. The nanoparticles were 
further conjugated with anionic penicillin-G (i.e. penicillin, hereafter) via electrostatic 
interaction between the cationic cobaltocenium moiety and anionic penicillin by mixing 
them together. Any unbound penicillin was removed by dialysis. 
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Scheme 4.2. Modification of iron oxide nanoparticles using cobaltocenium-containing 
polymer by RAFT. 
 
The mean diameter of cobaltocenium-containing nanoparticles was ~ 25 nm as 
measured by dynamic light scattering and was consistent with measurements obtained by 
TEM, as shown in Figure 4.3 a. After loading penicillin to the nanoparticle by electrostatic 
interaction, the diameter rose up to 33 nm as seen in DLS. The nanoparticle was also 
characterized by FTIR and EDX elemental analysis to confirm major chemical bonds and 
elements in the nanoparticles, respectively (Figure 4.1). 
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Figure 4.4 a) TEM image of FeNP-Cl nanoparticles; and b) Dynamic Light Scattering 
(DLS) measurements showing sizes of nanoparticles. 
Thermogravimetric analysis (TGA) was implemented to determine the accurate 
weight loss of nanoparticles after loss of attached organic compounds. The TGA of iron 
oxide nanoparticles with RAFT agent and cleaved polymer chains was compared with that 
of cobaltocenium-containing iron oxide nanoparticles alone. Based on the TGA 
measurement, the total weight percentage of cobaltocenium in the iron oxide nanoparticle 
(FeNP) was 56 wt%. It was found that cationic cobaltocenium moiety complexed with 
carboxylate anions of penicillin at a 1:1 pairing. This allowed us to calculate the final 
weight percentage of penicillin in the nanoparticles to be around 30 wt%.  
Antimicrobial Activity of Cobaltocenium-Containing Iron Oxide Nanoparticles 
The nanoparticles were tested for their antimicrobial activity against two different 
Gram-positive, Staphylococcus aureus (ATCC 33591) and Bacillus cereus (ATCC 11778), 
and three different Gram-negative bacteria, Escherichia coli (ATCC 11775), Proteus 
vulgaris (ATCC 33420) and Klebsiella pneumonia (ATCC 35596), by the conventional 
agar disk-diffusion assay following a protocol of Kirby Bauer diffusion test[54]. Initially, 
concentrations of penicillin ranging from 4 µg to 10 µg were tested. The optimal 
antibacterial activity was obtained with 7 µg penicillin and was used for all subsequent 
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disk diffusion assays. The development of a clear zone around the disk represents an 
inhibition zone, which indicates the ability of the test samples to kill the bacteria. To better 
compare the antimicrobial efficacy, four different samples were prepared for disk diffusion 
assays: homopolymer-penicillin conjugate (PCo-Pen), penicillin, FeNP-penicillin 
conjugate (FeNP-Pen) and FeNP without penicillin (FeNP-Cl). For S. aureus, the diameter 
of the inhibition zone caused by penicillin alone was 8 mm while the homopolymer 
conjugate resulted in a larger diameter of 11 mm, as shown in Figure 4.5. When the FeNP-
penicillin conjugate was used, the inhibition zone was significantly enhanced and 
diameters increased to a mean of 18 mm.  FeNP nanoparticles lacking penicillin had much 
smaller zones of inhibition owing to their much reduced antibacterial activity. When the 
assay was extended to another Gram-positive bacterium, B. cereus, a similar trend was 
observed, however, higher antimicrobial activities for all samples were observed. The 
zones of inhibition of penicillin and FeNP-penicillin conjugates increased to 10 mm and 
20 mm, respectively, when compared to S. aureus. For further investigation, disk diffusion 
assays were carried out against several BSL2-level Gram-negative pathogen strains using 
the above-mentioned protocol: Escherichia coli, Proteus vulgaris and Klebsiella 
pneumonia. As shown in Figure 4.5, penicillin alone showed minimal antibacterial activity 
when compared to homopolymer-penicillin conjugates and FeNP-penicillin conjugates. 
For example, inhibition zones caused by penicillin were just 4 mm against K. pneumonia, 
while inhibition zones created by FeNP-penicillin conjugate were three times higher (12 
mm). Inhibition zones caused by homopolymer conjugate (PCo-Pen) were larger than those 
of penicillin alone, but remained smaller than the FeNP-penicillin conjugates.  
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Figure 4.5. Inhibition zones of different agents against various strains of bacteria at an 
equivalent of 7 μg penicillin-G/disk using disk-diffusion assays: a) S. aureus; b) B. cereus 
C) E. coli; d) K. pneumoniae; e) P. vulgaris. 
The cationic moiety of cobaltocenium displayed good antimicrobial activity at a 
higher concentration, but the concentration of cobaltocenium in the FeNP-Cl was probably 
not high enough to result in determinable antimicrobial activity. Compared to penicillin 
alone, all FeNP-conjugates exhibited much stronger antimicrobial activities for both Gram-
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positive and Gram-negative strains.For penicillin and each of the FeNP-penicillin 
conjugates, minimum inhibitory concentrations (MIC) were calculated using the 
established protocol, and are given in Table 4.1[55]. The MIC values are based on the 
effective concentration of penicillin in the nanoparticle-penicillin conjugate. The mean 
MIC of FeNP-penicillin conjugates against Gram-positive strains, S. aureus was 3.4+0.4 
µg/mL and B. cereus was 2.7 +0.5 µg/mL, which was approximately four times lower than 
that of penicillin alone, 13.48 µg/mL and 10.92 µg/mL respectively, for these pathogens.  
Table 4.1 Minimum inhibitory concentrations (MICs) of different agents against five 
strains of bacteria. 
Entry Minimum Inhibitory Concentration (MIC µg/mL) 
 S. aureus B. cereus E. coli P. vulgaris K. pneumonia 
FeCo-Pen 3.4 2.7 5.6 6.5 7.6 
Penicillin 13.5 10.9 22.3 17.5 26.7 
As expected, the MIC values for three different Gram-negative strains were 
significantly higher. They followed a similar trend to the Gram-positive strains, and have 
much lower MIC values than those observed for penicillin alone. Compared with penicillin, 
nanoparticle-polymer conjugates produced significantly higher efficacies against both 
Gram-positive and Gram-negative strains. The additional outer polysaccharide layer (i.e. 
capsule) present in the Gram-negative bacteria might act as an extra layer of shielding for 
the test samples to penetrate, resulting in the observed smaller inhibition zones and higher 
MIC values.  
The increased bactericidal activity and inhibition effect of FeNP-penicillin 
conjugates on various Gram-positive and Gram-negative strains was further confirmed by 
confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). 
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LIVE/DEAD stained bacteria viability assays using CSLM indicated greater levels of cell 
death and lower cell densities when bacterial cells were exposed to FeNP-Pen conjugates, 
as shown in Figure 4.6. Cells incubated with FeNP-Pen conjugates displayed primarily red 
or yellow fluorescence, indicative of cell death, as determined by rupture of cell 
membranes. 
Figure 4.6. Confocal scanning laser microscopy (CSLM) images of controls and FeNP-
penicillin conjugates exposed to a concentration equivalent of penicillin 7 μg/mL. Cells S. 
aureus, B. cereus, E. coli, K. pneumonia and P. vulgaris were stained using BacLight 
Live/Dead stain, where green indicates live cells, and red indicates dead cells). The 
bacterial solution without FeNP was used as the control.  
Also, the SEM imaging was used to compare differences in morphology before- 
and after-treatment with FeNP-Pen conjugates as in Figure 4.7. Control samples consisted 
of intact bacterial cells with smooth surfaces while the cells incubated with nanoparticle 
conjugates displayed collapsed cell envelopes with obvious disruptions in the original 
morphology. We postulate that the high antibacterial efficacy resulted from the stable 
attachment of polymers to the nanoparticle surface, which in turn delivered increased 
densities of antibacterial species to the target bacterial cells. The bacterial cell wall is the 
primary target of β-lactam antibiotics such as penicillin, and bacteria usually resist these 
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antibiotics by secreting beta-lactamase enzymes, which cause the hydrolysis of the lactam 
ring and nullify the efficacy of antibiotic molecules. 
 
Figure 4.7 Scanning electron microscopy (SEM) images of control and FeNP-penicillin 
conjugates with a concentration of penicillin at 7 μg/mL against various Gram-positive and 
Gram-negative bacteria. Bacterial solutions without FeNP were used as the control. All 
scale bars are 2.0 µm. 
The synergistic introduction of two antimicrobial segments, cobaltocenium and 
penicillin, acts through different mechanisms against the pathogenic bacteria. Thus, the 
possibility of circumventing both mechanisms by bacteria, in addition to the local 
concentration effect provided by nanoparticles, is reduced. When antibiotics are 
administered in a solution form, the concentration of antibiotic reaching the pathogenic cell 
is much reduced as the resulting scenario is much different as they tend to form a 
homogenous dispersion of molecules spread over the tissues. 
One of the advantages using iron oxide nanoparticles is that the FeNP-penicillin 
conjugates can be easily extracted and recycled owing to the fast response to an applied 
magnetic field as shown in Scheme 4.3 and Figure 4.2 This not only saves the cost and 
time but also eliminates the possibility of nano-pollution in the biological environment. 
The dynamic shake flask method was used to evaluate the recyclability and antibacterial 
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efficacy of FeNP nanoparticle conjugates. The nanoparticle conjugates were shaken in a 
bacterial suspension at 37ᵒC for 4 hours, and OD600 was measured. 
Scheme 4.3 Schematic illustration of recycling cobaltocenium-containing magnetic 
nanoparticles for antibacterial application.  
 
The nanoparticle conjugates were readily collected at the side of the tube using a 
magnet and the supernatant was removed. To confirm the equimolar pairing of 
cobaltocenium moiety with anionic penicillin for the next cycle, a fresh batch of penicillin 
was added. The nanoparticles were washed multiple times with aqueous solution to remove 
any excess penicillin. Thus, obtained conjugates were re-dispersed in the bacterial solution 
and the procedure, mentioned earlier, was repeated. The enhanced inhibition efficiency of 
nanoparticle conjugates using the recycled nanoparticles against both Gram-positive and 
Gram-negative bacteria was retained even after five cycles as shown in Figure 4.8. 
Cobaltocenium-containing iron oxide nanoparticles have dual mode of action: cationic 
cobaltocenium can disrupt cell membranes and the antibiotics target cell walls. We 
conducted a dose-dependent time-kill study to investigate how rapid the nanoparticle 
conjugates can kill bacteria using a colony formation assay. After incubating overnight 
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with the nanoparticle conjugates, the solution was diluted and placed on an agar plate. The 
number of colony-forming units (CFU) was counted at various time up to 12 hours at the 
multiple of MIC concentration and expressed as CFUmL-1. 
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Figure 4.8 Inhibition activities of recyclable magnetic cobaltocenium-containing FeNP 
conjugates against Gram-positive (S. aureus) and Gram-negative bacteria (E. coli). 
As shown in Figure 4.9, nanoparticle conjugates started to act instantaneously, 
which can be seen by the significant reduction in bacteria concentration. With the 
concentration of just four times above the MIC, all bacteria (S. aureus) were completely 
killed in just 4 hours. When the concentration was increased to eight times of MIC, it took 
approximately one hour to kill all bacteria.  
One of the main concerns on antimicrobial agents is that over time the bacteria 
evolve as a part of their adaptive response, and develop resistance, which cause an array of 
diseases ranging from minor infections to persistent and life-threatening infections. To 
evaluate the probability of that FeNP-penicillin conjugates might elicit resistance in 
bacteria, a resistance-selection study was conducted against both Gram-positive and Gram-
negative bacteria using OD600 measurements.  Cultures were subsampled and transferred 
15 times to new media containing their respective antibiotic conjugates at MIC 
concentration. 
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Figure 4.9 Time-kill curves of FeNP-conjugates against S. aureus and E. coli.  Bactericidal 
activities were monitored for first 12 hours. The concentrations used were MIC, 4×MIC, 
and 8×MIC, respectively.  
As shown in Figure 4.10, the OD600 values of the nanoparticle conjugates remained 
virtually constant even after 15 consecutive passages, indicating the nanoparticle 
conjugates did not induce drug resistance against both S. aureus and E. coli. In addition, 
the MIC values for S. aureus after 15 passages did not show any significant spikes ruling 
out any possibilities of resistance development. The cobaltocenium-moiety has the 
capability to directly contact the bacterial cell wall causing disruption, which makes 
antibiotic resistance mechanism irrelevant for the conjugate system.  
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Figure 4.10 Drug resistance study of FeNP-penicillin conjugates against S. aureus and E. 
coli. 
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A typical bacterial cell is known to be in the micrometer range but the outer cell 
membranes consist of pores that are in the nanometer range. Thus, it enables the FeNP 
conjugates with diameters in the range of 30 nm to pass through the membrane to enter the 
cell causing the lysis of bacterial cells. As shown in Figure 4.11, the control bacterial cells 
are intact and have smooth surfaces. After treating with FeNP conjugates, outer cells 
membranes appeared to be disrupted with the entry of particles inside the cell and the 
bacterial cells seemed to have clumped together. This confers the particles can penetrate 
inside and cause lysis of bacterial cells.  
Hemolysis is the lysis of red blood cells (RBC) and is commonly characterized as 
a side effect of cationic polymers. Therefore, a hemolytic assay was conducted to evaluate 
whether FeNP particles could lead to hemolysis of RBCs. We found that even at a 
concentration as high as 500 µg/mL, extremely low percentages of cells (< 5%) were lysed 
by FeNP compared to the negative control group, as shown in Figure 4.3. This implies that 
the FeNP has negligible or no toxicity towards host cells. 
  
Figure 4.11 TEM images of S. aureus after incubating with (A) Control; and (B) FeNP-
conjugates, with the concentration of penicillin at 7 µg/mL. 
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4.5 Conclusions 
In summary, we designed and synthesized highly efficient charged 
metallopolymer-grafted magnetic nanoparticles via surface-initiated RAFT 
polymerization.  β-Lactam antibiotic penicillin-G was loaded onto the magnetic 
nanoparticles, based on electrostatic interaction between cationic cobaltocenium moiety 
and anionic antibiotic molecule. The resulting nanoparticle conjugates showed good 
bactericidal efficiencies against both Gram-positive and Gram-negative pathogenic strains, 
which facilitated the revitalization of the penicillin. These nanoparticles displayed a 
response to external magnetic fields and were easily recycled after antibacterial tests. The 
recycled nanoparticle conjugates retained aqueous dispersibility and high antibacterial 
efficacy. In addition, the nanoparticle conjugates killed bacteria rapidly, and the 
susceptibility of both Gram-positive and Gram-negative strains to the nanoparticle 
conjugates remains almost unchanged even after 15 passages. The conjugates improved 
the bactericidal efficacy not only by rejuvenating antibiotics but also by providing an 
enhanced local concentration effect on the bacterial cells.  
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CHAPTER 5 
GOLD NANOPARTICLES WITH COBALTOCENIUM-ANTIBIOTIC CONJUGATES 
TOWARD BROAD SPECTRUM ANTIMICROBIAL EFFICACY 
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5.1 Abstract 
Bacterial infections have evolved into one of the most urgent global health threats. 
Designing potent antimicrobial agents that can combat drug-resistant bacteria is essential 
for treating bacterial infections. In this report, we developed a strategy to graft 
metallopolymer-antibiotic bioconjugates on gold nanoparticles as an antibacterial agent to 
fight against different bacterial strains. Thus, these nanoparticle conjugates combined 
various components in one system to display enhanced bactericidal efficacy, in which small 
sized nanoparticles provide high surface area for bacteria to contact, cationic metal polymer 
frameworks interact with negatively charged cell membranes, and β-lactam antibiotics are 
revitalized with improved vitality to attack bacteria via evading the detrimental enzyme-
catalyzed hydrolysis. These macromolecular systems exhibited high efficacy in combating 
pathogenic bacteria, especially Gram-negative strains, due to synergistic effects of multi 
components on interactions with bacterial cells. 
5.2 Introduction 
Bacterial infections are one of the most dangerous health crises the word is facing. The 
consequences includes increased healthcare cost, destruction of local tissues, patient 
disability, morbidity, and even death.1-3 According to a study on antimicrobial resistance 
in 2014,4 bacterial infections currently cause at least 50,000 deaths annually across the US 
and Europe, with significantly higher numbers in other areas. If more-effective strategies 
are not taken to prevent and treat bacterial infections, it has been predicted that by 2050 
infections could claim 10 million lives with costs approaching $100 trillion (USD) dollars 
worldwide.4 However, commonly-used antibiotics, such as penicillin and methicillin, have 
diminished antimicrobial efficacies and/or are ineffective against numerous multidrug-
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resistant (MDR) bacterial pathogens because of overuse of these drugs for so many years. 
5, 6 Therefore, restoring the vitality of conventional antibiotics or designing other potent 
antimicrobial agents that combat drug-resistant bacteria is essential for treating bacterial 
infections.7, 8 
In recent years, cationic compounds and polymers,9-11 such as quaternary 
ammonium,12-14 phosphonium compounds,15 and peptides16, 17  have garnered a great deal 
of attention as antimicrobial agents because of their ability to adsorb onto the negatively-
charged bacterial cell surfaces and to insert their hydrophobic groups into membranes to 
combat bacteria. But many of these antimicrobial agents are notoriously toxic towards 
mammalian cells due to physical damage of cell morphology, thus limiting their roles in 
clinical settings. 10 Recently, we reported a class of non-cytotoxic antimicrobial cationic 
metallopolymers,18, 19 which could form bioconjugates with conventional β-lactam 
antibiotics, such as penicillin, amoxicillin and cefazolin, via unique ion-pairs between 
cationic metallocenium moieties and carboxylate anions. The bioconjugates efficiently 
protected β-lactam antibiotics from hydrolysis by a β-lactamase enzyme in bacteria and 
lysed different strains of methicillin-resistant Staphylococcus aureus (MRSA). 
Compared with antibiotic molecules or polymers, nanoparticles (NPs) provide versatile 
platforms for therapeutic applications based on their physical properties.20-23 For example, 
the size range of NPs is commensurate with biomolecular and bacterial cellular systems, 
providing additional interactions to small molecular antibiotics.24-27 The high surface to 
volume ratio allows incorporation of abundant functional ligands, enabling multivalency 
on NP surface to enhance interactions to target bacteria.28-31 The inherent features of gold 
nanoparticles (Au NPs) provides  advantages of small size, large surface area, 
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straightforward surface modification by thiols and amines, not being the substrate of 
bacterial efflux pumps, and the safety approval by U.S. FDA , which allow Au NPs to be 
useful as antibacterial agents.32-39 
Herein, we developed a strategy to fight against different strains of Gram-positive and 
Gram-negative bacteria by presenting metallopolymer-antibiotic bioconjugates on gold 
nanoparticles as an antibacterial agent to further enhance the activity of conventional β-
lactam antibiotics. A variety of characterization techniques, including transmission 
electron microscopy (TEM), dynamic light scattering (DLS), thermal gravimetric analysis 
(TGA), Zeta-potential analysis, UV-visible spectra, and 1H NMR, spectra were performed 
systematically to determine the formation of Au@PCo NPs (cobaltocenium polymers 
coating on Au NPs). After bio-conjugating with β-lactam antibiotic penicillin-G, the 
Au@PCo-Peni NPs showed enhanced antibacterial efficacy on both Gram-positive and 
Gram-negative bacteria, compared with homopolymer-penicillin conjugates and penicillin-
G alone. Confocal laser scanning microscopy (CLSM), scanning electron microscopy 
(SEM) and TEM indicated that Au@PCo-Peni NPs can penetrate bacteria membranes and 
destroy their permeability, causing the bacterial death. 
5.3 Experimental Section 
Characterization  
1H (400 MHz), 1NMR spectra were recorded on a Varian Mercury 400 NMR 
spectrometer with tetramethylsilane (TMS) as an internal reference. Mass spectrometry 
was conducted on a Waters Micromass Q-TOF mass spectrometer, and the ionization 
source was positive ion electrospray. Dynamic light scattering (DLS) and Zeta-potential 
were operated on a Nano-ZS instrument, model ZEN 3600 (Malvern Instruments).  UV−vis 
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was carried out on a Shimadzu UV-2450 spectrophotometer with a 10.00 mm quartz 
cuvette and monochromatic light of various wavelengths over a range of 190−900 nm. 
Field-Emission Scanning Electron Microscopy (FE-SEM, Zeiss UltraPlus) was used to 
take images of bacterial cells after incubating overnight with test drugs. The samples were 
firstly coated with gold using Denton Dest II Sputter Coater for 45 s and then observed by 
SEM. A Hitachi 8000 transmission electron microscope (TEM) was applied to take images 
at an operating voltage of 150 kV. TEM samples were prepared by dropping solution on 
carbon-supported copper grids and then dried before observation. 
Materials and Methods 
2-Cobaltoceniumamidoethyl methacrylate hexafluorophosphate (CoAEMAPF6) was 
synthesized according to our earlier report.40 2-Aminoethyl methacrylate hydrochloride 
(90%), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC-HCl, 
98%), 4-(dimethylamino) pyridine and tetrabutylammonium chloride (TBACl) were 
purchased from Aldrich and used as received. Tetrakis(hydroxymethyl)phosphonim 
chloride (referred to hereafter as THPC) was an 80% aqueous solution (practical grade) 
from Fluka, chloroauric acid (hydrogen tetrachloroaurate(III)) was from Johnson Matthey, 
assayed at 49.42 %. Water was from Thermo Scientific Nanopure with ion conductivity at 
18.2 MΩ. The following bacterial strains were purchased from ATCC: Staphylococcus 
aureus (S. aureus, ATCC-33591), Escherichia coli (E. coli, ATCC-11775), Klebsiella 
pneumoniae (K. pneumoniae, ATCC-35596), and Pseudomonas aeruginosa (P. 
aeruginosa, ATCC-10145). Nitrocefin was purchased from TOKU-E and used as received. 
Sodium salt of penicillin-G was purchased from VWR and used as received. 2-Cyano-2-
propyl benzodithioate (CPB) was obtained from Strem Chemical Inc. CPDB immobilized 
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silica nanoparticles were synthesized according to the literature. Azobisisobutyronitrile 
(AIBN) was recrystallized from methanol before use. All other chemicals were from 
commercial sources and used as received. 
Synthesis of poly(cobaltocenium (PCo) homopolymers.  
Cobaltocenium monomer, 2-cobaltoceniumamidoethyl methacrylate 
hexafluorophosphate (CoAEMAPF6), was synthesized according to a reported method.  
PCo homopolymers were synthesized via RAFT polymerization:40, 45 CoAEMAPF6 (490 
mg, 1.0 mmol),  and CPB (3.5 mg, 0.01 mmol) and AIBN (0.5mg, 0.003mmol) were 
dissolved in a 1.0 mL DMF solution in a 10 mL Schlenk flask and then degassed by purging 
N2 for 30 min. The mixture was then heated at 90 
oC for 1-2 h. After reaction, the mixture 
was precipitated in cold dichloromethane for three times and vacuum-dried. Finally, the 
PCo homopolymers became soluble in water through a facile phase-transfer ion-exchange 
from PF6
- to Cl- using TBACl according to a previous report. A typical procedure was as 
follows:1 mL PF6
- paired PCo homopolymers (30 mg/mL in acetonitrile) was slowly 
dropped into 5 mL TBACl solution (in acetonitrile) under vigorous stirring. After stirring 
for 5 minutes, the precipitated Cl- paired PCo homopolymers was collected and washed by 
acetonitrile three times to remove any remaining PF6
- anions and excess TBACl. The solid 
copolymer was then vacuum-dried and collected. 
Synthesis of Au@PCo Nanoparticles. 
Gold nanoparticles were synthesized according to a reported method.44 In a 100-
mL round-bottomed flask , while stirring, with 45.5 mL of water and then, in order, portions 
of aqueous solutions of sodium hydroxide (0.2 M, 1.5 mL), the reducing agent THPC (1 
mL of a solution of 1.2 mL of 80% aqueous solution diluted to 100 mL with water), and 
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the metal salt chloroauric acid (2 mL of dark-aged stock solution, 25 mM) results in the 
formation of orange-brown hydrosols of gold nanoparticles. The Au@PCo nanoparticles 
were prepared as following43: the PCo polymer (50 mg) was added to above gold NPs 
solution. Then, 1M NaBH4 (2 mL) was added dropwise and the mixture was stirred at room 
temperature for 48h. The mixture was centrifuged for 1h at 13,000 rpm. After centrifuge 
and rinsing with water 3 times, the Au@PCo nanoparticles were obtained. 
Synthesis of Au@PCo-Peni Nanoparticles. 
Au@PCo NPs (15 mg) and antibiotic penicillin-G sodium salt (10 mg) were 
dissolved in deionized water (1 mL) with molar ratios (penicillin salt to cobaltocenium 
moieties) between of 1.1 to 1. The solution was stirred for 12 h and then dialyzed against 
3L deionized water for 12 h. The solution in a dialysis bag was collected and freeze-dried. 
The Au@PCo-Peni nanoparticles was obtained.  
Evaluation of antimicrobial effects. 
The following bacterial strains were purchased from ATCC: Staphylococcus 
aureus (S. aureus, ATCC-33591), Escherichia coli (E. coli, ATCC-11775), Klebsiella 
pneumoniae (K. pneumoniae, ATCC-35596), Proteus vulgaris (P. vulgaris, ATCC-
33420). For these bacteria, a single colony was inoculated in 30 mL Tryptic Soy broth 
(TSB) at 37 °C for 24 h, shaking at 190 rpm/min. All bacteria were grown to an optical 
density of about l.00 (OD600 = 1.00) for further use. 
To conduct the agar disk-diffusion assays, actively-growing cultures of each 
bacterial strain on Mannitol salt agar (MSA) were inoculated on TSB agar plates. The 
bacterial growth culture (cell concentrations were 1.0 × 106 CFU/mL) 10 μL was diluted 
to 1 mL in TSB, and 100 μL of that was spread on TSB agar plates to form a bacterial lawn 
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covering the plate surface. Then 6 mm (diameter) filter discs were added to the plate 
surface. Penicillin-G, Au@PCo NPs or Au@PCo-Peni bioconjugates at different amounts 
in 30 μL water was added to disks, and the plates were incubated at 28oC for 18 h. The 
development of a clear zone around the disk was indicative of the ability of agents to kill 
bacteria. 
The minimum inhibitory concentrations (MIC) of PCo copolymers and PCo 
homopolymers were determined. 50 μL aqueous solution of PCo copolymers or PCo 
homopolymers with different concentrations were added to 96-well plates. Then, 150 μL 
bacterial TSB solution (OD600 = 1.00) was added to the wells. The bacterial TSB solution 
without polymers was used as the control. The assay plate was incubated at 37oC for 12 
hours. Bacterial growth was detected at OD600 and was compared to controls of bacterial 
TSB solution without polymers. All assays were carried out in duplicate in the same assay 
plate. Inhibitory percentages were calculated by following equation.  
Inhibition% =
𝑂𝐷600(𝑡) − 𝑂𝐷600(0)
𝑂𝐷600(𝑡)𝑐 − 𝑂𝐷600(0)𝑐
 
Here, OD600 (0) indicates the initial OD600 value, and OD600 (t) is the OD600 value for 
bacteria after incubation with polymers for t hours. OD600 (0)c is the initial OD600 value and 
OD600 (t)c is the OD600 value for control samples after incubation for t hours. 
LIVE/DEAD bacterial viability assays.  
The six bacteria strains were inoculated and prepared by a similar procedure used 
for inhibitory concentration determination studies. 1 mL of active bacterial stock of 
bacteria strains was introduced to 18.5 μg Au@PCo-Peni NPs (penicillin-G weight: 5μg). 
An untreated cell suspension was used as the control. Following 18 h incubation at 37 oC, 
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1 μL LIVE/DEAD BacLight (Bacterial Viability Kit; Invitrogen Inc.) was added to the 
incubation solution. After incubation for 15 minutes, cells were imaged using a Leica TCS 
SP5 CLSM with 63X oil immersion lens. When excited at 488 nm with Argon and 
Helium/Neon lasers, bacteria with intact membranes display green fluorescence (Emission 
= 500 nm) and bacteria with disrupted membranes fluoresce red (Emission= 635 nm). 
Bacterial morphology assays. 
The morphologies of different bacteria after incubation Au@PCo-Peni NPs were 
examined by FE-SEM with a similar procedure. In general, 10 μL of bacteria cell solution 
was grown on one glass slide in 12-well plate containing 1 mL TSB medium at 37 oC 
overnight. Cell suspensions were diluted to OD600 = 1.0. 18.5 μg Au@PCo-Peni 
bioconjugates (penicillin-G weight: 5μg) was added to the 1 mL cell stock solution, 
respectively and incubated at 37 oC overnight. A cell suspension without any chemicals 
was used as the control. The samples were then fixed in cacodylate buffered with 2.5% 
glutaraldehyde solution (pH = 7.2) for 2–3 h at 4 oC and post-fixed with 1% osmium 
tetraoxide at 4 oC for 1 h. The samples were dried under critical point, then coated with 
gold using Denton Dest II Sputter Coater for 120 s and observed by FE-SEM. An untreated 
cell suspension was used as the control. 
5.4 RESULTS AND DISCUSSION 
The cationic cobaltocenium polymer (PCo) was first synthesized via reversible-
addition fragmentation chain transfer (RAFT) polymerization40, 41 using 2-cobaltocenium 
amidoethyl methacrylate hexafluorophosphate (CoAEMAPF6) as a monomer, 2-Cyano-2-
propyl benzodithioate (CPB) as a chain transfer agent (CTA) (Scheme 1). The PCo 
polymer became hydrophilic and highly soluble in water after facile phase-transfer ion-
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exchange from PF6
– to Cl– using tetrabutylammonium chloride (TBACl) as an ion-
exchange reagent.42 Then, the dithioester end groups of RAFT agent in PCo polymer were 
reduced to thiol groups by NaBH4 in aqueous media at ambient temperature. The thiol end-
capped PCo could be coated on Au-NPs to form Au@PCo nanoparticles by a “grafting-to” 
approach.43 Finally, a bioconjugate between cationic PCo and anionic β-lactam antibiotics 
such as penicillin-G could circumvent major enzymatic hydrolysis via β-lactamase(s) and 
thus resume the effectiveness of antibiotics on attacking bacteria. 
Scheme 5.1 a) Synthesis of cationic thiol end-capped cobaltocenium polymers by RAFT 
polymerization and dithioester reduction. b) Synthesis of antimicrobial Au@PCo-Peni 
nanoparticles by a “grafting-to” approach and a bioconjugation between cationic PCo and 
anionic β-lactam antibiotic Penicillin-G. 
 
Compared with 1H NMR spectrum of CoAEMAPF6 monomer, the vinyl proton 
signals from methacrylate double bond at ∼6.10 and ∼5.70 ppm disappeared in PCo 
polymers. Meanwhile, the three peaks at ∼6.25 to ∼5.80 ppm corresponding to the 
cyclopentadienyl (Cp) rings of the cobaltocenium unit remained, indicating the successful 
polymerization of cobaltocenium monomers. The final molecular weight of PCo could be 
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determined by tracking the NMR conversion during the polymerization process. Three 
cobaltocenium polymers with different molecular weight, respectively, 6,000 g/mol (noted 
as PCo-6K), 15,000 g/mol (PCo-15K), 30,000 g/mol (PCo-30K), were finally synthesized. 
 
Figure 5.1 TEM images of a) Au NPs, b) Au@PCo-6K, c) Au@PCo-15K, and d) 
Au@PCo-30K.  
Au NPs were prepared using chloroauric acid as the precursor, 
tetrakis(hydroxymethyl)phosphonium chloride (THPC) as the reducing agent, which could 
produce ultrafine gold particles.44 TEM and DLS showed the diameter of Au NPs was 
about 2-3 nm (Figure 5.1a). After coating PCo polymers with different molecular weights, 
we got three sets of Au@PCo NPs (referred to as Au@PCo-6K, Au@PCo-15K and 
Au@PCo-30K).  TEM images indicated all Au@PCo NPs had good dispersions (Figure 
5.1b-d). As expected, the size of Au@PCo NPs increased to ~4 nm (Au@PCo-6K), 6 nm 
(Au@PCo-15K) and 9 nm (Au@PCo-30K), respectively, with the increase of molecular 
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weight of PCo polymers. DLS analysis further confirmed the increased sizes of Au@PCo 
NPs under different polymer molecular weight as shown in Figure 5.2a.  
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Figure 5.2 a) Size distribution of different gold nanoparticles analyzed by DLS. b) UV-vis 
absorption spectra of various samples c) TGA data of Au NPs, PCo homopolymers and 
Au@PCo NPs with different cobaltocenium polymer molecular weights. d) TGA data of 
Au@PCo-15K NPs, penicillin-G and Au@PCo-Peni. 
The successful surface functionalization of gold nanoparticles with cationic 
cobaltocenium ligands was also analyzed by Zeta-potential analysis, UV-Vis and NMR. 
Compared to the negative zeta potential of Au NPs at -26 eV, the mean positive potential 
of all Au@PCo NPs increased to about +40 eV. The UV-visible absorption of Au NPs only 
had a broad shoulder under the ultraviolet region, while the spectrum of Au@PCo NPs 
showed an obvious absorption peak of cobaltocenium polymer at 280 nm (Figure 5.2b). 
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We first evaluated antimicrobial activities of Au NPs, PCo and Au@PCo NPs 
against Gram-positive bacteria S. aureus and Gram-negative bacteria K. pneumonia using 
disk-diffusion assays. The ability of the compound to kill the bacteria was represented by 
the development of a clear zone around the disk, also known as the inhibition zone. As 
expected, Au NPs alone could not inhibit the proliferation of S. aureus and K. pneumonia 
even at high concentrations. Compared with PCo-15K homopolymers, the Au@PCo-15K 
NPs showed significantly enhanced activities against both S. aureus and K. pneumonia at 
different concentrations. However, there was more significant molecular weight-dependent 
response on bacterial proliferation for PCo homopolymers than that for the Au@PCo NPs.  
For example, the PCo-15K homopolymers displayed the biggest inhibition zone against 
both S. aureus and K. pneumonia (Figure 5.3a) compared with PCo-6K and PCo-30K 
homopolymers. While the Au@PCo-15K NPs also exhibited the highest antimicrobial 
activity, the difference of activities among these three Au@PCo NPs was very small, 
especially for Gram-negative bacteria K. pneumonia. In order to further enhance the 
antimicrobial activity of Au@PCo NPs, we then studied bioconjugates of Au@PCo NPs 
with a β-lactam antibiotic, for which we chose penicillin-G. We simply mixed penicillin-
G with Au@PCo-15K NPs to form a bioconjugate (labeled as Au@PCo-Peni) via ionic 
complexation between cationic cobaltocenium and anionic antibiotic. TGA data (Figure 
5.2) suggested that the weight percentage of penicillin-G in the Au@PCo-Peni NPs was 
about 27%, with a molar ratio of cobaltocenium to penicillin-G at ~ 1:0.8. Disk-diffusion 
assays were first used to evaluate antimicrobial activities of Au@PCo-Peni bioconjugates 
against four strains of bacteria including Gram-positive bacteria (S. aureus) and Gram-
negative bacteria (E. coli, K. pneumoniae and P. aeruginosa). To better compare 
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bactericidal efficiency, we prepared a bioconjugate only containing polycobaltocenium 
(15,000 g/mol) and penicillin-G as a control. Initially, various amounts of penicillin-G 
ranging from 5 µg to 15 µg was tested. As shown in Figure 5.3a, when the amount of 
penicillin-G was 5 μg, penicillin-G alone exhibited minimal antimicrobial efficacy against 
S. aureus. In contrast, PCo-Peni and Au@PCo-Peni bioconjugates displayed clear zones 
of inhibition, which increased to 11 mm and 14.5 mm, respectively. By increasing the 
amount of penicillin-G to 10 μg, the inhibition zones of penicillin-G, PCo-Peni, and 
Au@PCo-Peni appreciably increased to 9.5 mm, 15 mm and 19 mm, respectively. At the 
highest amount of penicillin-G (15 μg), Au@PCo-Peni still showed the biggest inhibition 
zone (21 mm), compared with penicillin-G (15 mm) and PCo-Peni (20 mm). For Gram-
negative bacteria, penicillin-G showed much lower antimicrobial activity as compared to 
Gram-positive bacteria. Even by increasing the amount of penicillin-G to 10 μg, penicillin-
G alone showed minimal antibacterial activity against all three Gram-negative bacteria 
(Figure 5.3a ii-iv). This is because Gram-negative bacteria possessed double membranes 
with a variety of additional resistance mechanisms to evade antibiotics. Using 
nanoparticles as antimicrobial agents could increase the permeability of bacterial 
membranes and enhance antimicrobial activity against Gram-negative bacteria. As shown 
in Figure 2a, Au@PCo-Peni NPs exhibited the strongest antimicrobial activities against all 
three Gram-negative at different amount of penicillin-G.  
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Figure 5.3 a) Disk-diffusion assays against (i) S.aureus (i)E. coli, (i) K. pneumonia, and 
(iv) P.  vulgaris of penicillin-G, PCo-Peni and Au@PCo -Peni NPs. b) OD600 values and 
c) inhibitory percentage of four bacteria incubated with penicillin-G, PCo-Peni and 
Au@PCo-Peni NPs, respectively. The bacterial TSB solution without antimicrobial agents 
was used as the control. 
To better quantify the inhibition efficacy of Au@PCo-Peni NPs, bacteria were 
incubated with different antimicrobial agents in TBS solution for 8 h.  Then, bacterial 
growth was detected with OD600 (Figure 5.3b) and inhibitory percentages (Figure 5.3c) 
were calculated, compared to controls of bacterial TSB solution without agents. As for S. 
aureus, the OD600 value of Au@PCo-Peni NPs was only 0.03, which was approximately 
55 times lower than that of the control (1.65), 13 times lower than penicillin-G (0.39), and 
8 times lower than PCo-Peni (0.25), respectively (Figure 5.2b). The inhibitory efficiency 
of Au@PCo-Peni against S. aureus increased to 98.5% from 84.5% (PCo-Peni) and 76.8% 
(the control) as shown in Figure 5.2c. The similar antibacterial trends and inhibitory 
efficiency were also found for other Gram-negative bacteria, which was consistent with the 
results from the disk-diffusion assays.  
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Table 5.1 The Minimum Inhibitory Concentrations of different antimicrobial agents 
against Gram-positive and Gram-negative strains. 
Compounds Minimum Inhibitory Concentration (µg/mL) 
 S. aureus E. coli K. pneumonia P. vulgaris 
Penicillin-G 15.8 20.4 23.2 22.6 
PCo-Peni 6.4 8.3 8.9 7.8 
Au@ PCo-Peni 2.6 4.5 5.4 4.9 
 
The Minimum Inhibitory Concentrations (MICs) of penicillin-G, PCo-Peni and 
Au@PCo-Peni against different Gram-negative strains are given in Table 5.1.  It should be 
mentioned that the MIC values are based on the effective concentration of penicillin in the 
polymer-penicillin conjugates. The MICs of Au@PCo-Peni NPs against S. aureus was 2.6 
μg/mL-1. These values are significantly lower than those of PCo-Peni (6.4 μg/mL-1) and 
penicillin-G (15.8 μg/mL-1). Similarly, as for three Gram-negative strains, MIC values of 
Au@PCo-Peni conjugate are almost 2~3 times less than PCo-Peni and 4~5 times less than 
penicillin-G alone. 
The inhibition effects by Au@PCo-Peni NPs on the four bacterial strains were further 
confirmed by Confocal Laser Scanning Microscopy (CLSM) and Scanning Electron 
Microscopy (SEM). Results of LIVE/DEAD bacterial viability assays using CLSM 
suggested almost all bacteria incubated with Au@PCo-Peni NPs were killed, with CLSM 
micrographs displaying obvious red or yellow fluorescence from dead bacteria as in Figure 
5.4a. From FESEM images in Figure 5.4b, we can observe that the Au@PCo-Peni NPs 
damaged bacterial membranes, made bacteria shrink and effectively killed them, while the 
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untreated bacteria (control groups) exhibited a typical spherical or rod morphology with a 
smooth surface. 
 
Figure 5.4 a) CLSM and b) SEM images of the control and Au@PCo-Peni NPs (18.5 
μg/mL, with the concentration of penicillin-G at 5 μg/mL) against various strains of 
bacteria. CLSM using BacLight live/dead stain, green indicates live cells, red indicates 
dead cells. Bacteria concentration was 1.0×106 CFU/mL. All scale bars in SEM images are 
2 µm. 
TEM showed Au@PCo-Peni NPs aggregated around bacterial membranes and then 
penetrated bacteria, making the outer bacterial membranes disrupted, while the control 
bacterial cells kept intact and smooth surfaces (Figure 5.5). All these studies suggested the 
Au@PCo-Peni NPs have excellent antimicrobial efficiency against broad-spectrum 
bacteria.  
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Figure 5.5. TEM images of the control and Au@PCo-Peni NPs (18.5 μg/mL, with the 
concentration of penicillin-G at 5 μg/mL) against S.aureus and E.coli. Bacteria 
concentration were 1.0×106 CFU/mL. All scale bars are 1 µm. 
 
The high bactericidal efficacy of Au@PCo-Peni NPs resulted from three synergistic 
effects: i) the cationic cobaltocenium motif can interact with the negatively-charged 
bacterial membrane enabling Au@PCo-Peni NPs to attach on the surface of bacteria more 
closely; ii) the small sizes of nanoparticle provided larger bacterial contact area of 
Au@PCo-Peni NPs to enhance their permeability into membranes and penetrate more 
easily; iii) once NP conjugates enter bacterial cells, the cobaltocenium motif would release 
penicilin-G and bind to β-lactamase, which can block the electrostatic chelation between 
penicillin-G and amino acid residue of β-lactamase preventing hydrolysis of penicillin-G. 
Finally, we analyzed the toxicity of Au@PCo NPs on red blood cells (RBCs) by evaluating 
whether they could lead to hemolysis of RBCs. We found that even at a concentration as 
high as 500 µg/mL, the lysis of RBCs was extremely low (< 10%) compared to the negative 
control group (Figure 5.6), suggesting low cytotoxicity to mammalian cells. 
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Figure 5.6 Hemolysis test results for Au@PCo nanoparticles. 
5.5 Conclusions 
In summary, we have developed a strategy to present metallopolymer-antibiotic 
bioconjugates on gold nanoparticles as an antibacterial agent to fight against different 
strains of Gram-positive and Gram-negative bacteria. The thiol end-capped cobaltocenium 
polymers could be easily coated on Au nanoparticles to form Au@PCo NPs by a “grafting-
to” approach. After bio-conjugating with an anionic β-lactam antibiotic penicillin-G, the 
formed cationic Au@PCo-Peni NPs with a small size and a large contact area can attach 
to the membranes of bacteria more closely, improve the vitality of penicillin-G and kill 
bacteria more effectively. We hope these multifunctional metallopolymer-based 
nanoparticles could be further explored in combating clinic infections by the pathogens 
resistant to conventional antibiotics. 
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CHAPTER 6 
SUMMARY AND OUTLOOK
 123 
6.1 Dissertation Summary 
A unique combination of organic and inorganic components in one macromolecular 
system offers exciting science for many areas, including medicinal chemistry, energy-
related science, and advanced catalytic chemistry. Thus, a full benefit could be achieved 
by simultaneously incorporating the mechanical and processing properties of polymeric 
frameworks and the electronic, catalytic, magnetic and radioactive properties of metal 
building blocks. The study of electrostatic charge on the relative affinity and comparison 
of the relative binding strength of a cobaltocenium-containing polyelectrolyte was carried 
out initially. It was demonstrated that low cytotoxic cationic cobaltocenium 
metallopolymers have antimicrobial efficacy against various bacterial strains including 
multidrug resistant bacteria by disarming activities of β-lactamase. We devised new 
strategy of developing novel materials using nontraditional therapy combining 
nanoparticles, antibiotics, and metal-containing macromolecules in nullifying multiple 
strains of bacteria with high antimicrobial efficacy. Silica and iron oxide nanoparticles 
grafted with charged cobaltocenium-containing metallopolymers were synthesized by 
surface-initiated reversible addition-fragmentation chain transfer (RAFT) polymerization 
using “grafting-from” strategy. These nanoparticles were characterized in detail. Both the 
nanoparticle conjugates displayed enhanced antimicrobial activity and did not induce 
bacterial resistance and were safe to use in animals with little to non-toxicity. Iron oxide 
nanoparticles displayed magnetic property so that it could be recycled without losing its 
effectiveness for multiple cycles. “Grafting-to” technique was utilized to make 
cobaltocenium-containing gold nanoparticles.  The thiol end-capped cobaltocenium 
polymers was obtained after reducing the polymer with RAFT agent end groups and coated 
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on gold nanoparticles to form cobaltocenium-containing gold nanoparticles. The improved 
bactericidal efficiencies of all these nanoparticle conjugates could be attributed to the joint 
act of multiple components in the nanoparticle system.  A cationic metal-containing 
macromolecular framework binds to the outer membrane via electrostatic interactions and 
nanoparticle surface provides enhanced local concentration of cobaltocenium-penicillin 
complex A bioconjugate between metal-containing macromolecules and conventional β-
lactam antibiotics could circumvent major enzymatic hydrolysis and thus resume the 
effectiveness of antibiotics attacking peptidoglycan which is critical for cell wall synthesis. 
Together, these multiple killing components provide multifaceted and versatile means for 
penetrating cellular barriers to fight bacterial resistance. 
6.2 Future Work 
Metallopolymers incorporates metal centers and macromolecules leading to 
materials that merge the electronic, magnetic and catalytic properties of metal with the 
mechanical and processing capability of polymeric frameworks. However, the 
development of efficient and scalable synthetic methodologies to make metallocenium 
derivatives is still challenging. So, metallocenium chemistry should be developed in 
several directions before it gains wide spread applications to prepare various functional 
materials. Although this dissertation demonstrated a promising way to make novel 
metallocenium-containing antimicrobial materials, further investigations are required to 
explore the synthesis of other materials. It could provide a new pathway for designing 
multifunctional macromolecular scaffolds to regenerate vitality of conventional antibiotics 
to kill multidrug resistant bacteria and address potential bacterial resistance. Future 
research should expand to drug-resistant strains including in vivo studies to establish the 
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relevance of these conjugates as drugs. Further structural modifications and tailoring will 
be necessary to make the metallopolymer conjugates more effective against drug-resistant 
Gram-negative pathogens, which possess double membranes with a variety of additional 
resistance mechanisms to evade antibiotics. Also, the polymer backbone should be 
switched from methacrylate to biodegradable backbone so the polymeric contents will be 
eliminated from the biological system following their action. Microbial biofilms are the 
source of a majority of infections so the field of metallopolymers should move forward 
with more focus on antibiofilm research. Particularly, future research can target the 
microbial communication system (quorum sensing) to control their biofilm formation. 
Quorum sensing plays an active role in regulating the microbial biofilm so the 
incorporation of strategies that inhibit microbial quorum sensing can provide a major boost 
to address the issue of biofilm. One of the ways can be by conjugating or incorporating 
various quorum sensing inhibitors with metallopolymers.  
Considering the unique properties of cationic cobaltocenium moieties, another 
direction to explore would be to make novel stimuli responsive block cobaltocenium-
containing block copolymers to carry out behavior and morphology studies. Metallocene-
containing polyelectrolytes are inherently redox responsive and thus the introduction of 
another stimuli-response will yield multi-responsive polymers. The combination of 
functional metallocenium with other biomacromolecules such as DNA can result in a 
colloidally stable polyplex which provides the opportunity for gene delivery. Another 
direction worth to explore will be to make poly(ionic liquids) using metallocenium 
monomers which could have applications in multitude of fields such as thermoresponsive 
materials, porous polymers, energy harvest and biomedicine. 
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